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ABSTRACT 
 
Evaluating a Stepped Care Protocol for Postpartum Depression in a Pediatric Primary Care 
Clinic 
by 
Sarah Courtney Smith 
Postpartum depression (PPD) is a prevalent, complex illness impacting 10% to 20% of mothers 
and their families. Treatments for PPD, such as medication and psychotherapy, are effective at 
reducing the severity of symptoms and generally improving quality of life for new mothers and 
their families. Unfortunately, many mothers with PPD go unrecognized due to a lack of 
standardized screening methods. Further, mothers regularly encounter barriers to accessible, 
evidence-based follow-up care to treatment even when symptoms of PPD are detected. The use 
of a stepped care protocol, set in a pediatric primary care clinic, is one proposed strategy to 
address the insufficient rates of screening, detection, and maternal contact with treatment. This 
study examines the feasibility of implementing a stepped care protocol to screen and provide 
brief therapeutic treatment to mothers reporting symptoms of PPD in one pediatric primary care 
clinic. The RE-AIM (reach, effectiveness, adoption, implementation, and maintenance) 
framework was used to evaluate implementation outcomes. Results suggest this stepped care 
protocol was feasibly implemented in one pediatric primary care clinic. The protocol was largely 
successful in screening mothers at a majority of well child checks (83.76%) for PPD and 
connecting them with resources based on the severity of symptoms reported. Future studies 
should further evaluate the impact brief onsite mental health treatments have on reports of PPD 
symptoms, longitudinal maternal and child outcomes as a result of the protocol, as well as the 
protocol’s replicability to pediatric practices elsewhere. 
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CHAPTER 1 
INTRODUCTION 
Prevalence and Terminology  
Interest in the prevalence rates and treatment of maternal depression has increased over 
the past two decades. The publication of the U.S. Surgeon General’s Report on Mental Health 
(2000) catalyzed a call to arms to healthcare providers to detect and treat depression in women 
following childbirth (US Public Health Service, 2000). Soon after the report, PPD was classified 
as the most common postnatal complication (Wisner, Parry, & Piontek, 2002). However, 
prevalence and definitions across the globe appear widely varied in published literature. A recent 
meta-analysis (Norhayati, Hazlina, Asrenee, & Wan Emilin, 2015) found the prevalence of PPD 
ranges from 1.9% to 82.1%, with Germany reporting the lowest percentage and the United States 
reporting the highest rate and with the greatest range (3.4% to 82.1%). Commonly cited rates of 
occurrence fall in the range of 10% to 20% of mothers (Gaynes et al., 2005; Gold, 2002; O’Hara 
& Swain, 1996), and the American Academy of Pediatrics asserts about 12% of children are born 
to mothers with PPD every year (APA, 2010), with rates doubling in low-income and teenage 
mothers in the United States (Isaacs, 2004). 
There are several labels used to describe depressive symptoms occurring around the time 
of childbirth. PPD terminology is varied in the literature based on symptom clusters and 
symptom onset. Postpartum blues, more colloquially referred to as the “baby blues,” occurs in 
about 50% to 85% of women immediately following delivery, with symptoms peaking in 
severity around the fourth day, then remitting naturally within about 10 days to 2 weeks (Cohen 
et al., 2010). Symptoms include, but are not limited to, brief crying spells, sadness, poor sleep, 
and irritability. These symptoms appear consistent with major depressive disorder symptoms; 
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however, due to the brevity and mild severity, postpartum blues do not typically require 
treatment. On the other end of the spectrum is postpartum psychosis, a rare (0.1%-0.2%) 
occurrence that includes symptoms of paranoia, disorganized thoughts, impulsivity, 
hallucinations, delusions, and possible thoughts of infanticide and suicide. The severity of 
postpartum psychosis requires immediate treatment, such as a psychiatric evaluation and possible 
hospitalization (Guille, Newman, Fryml, Lifton, & Epperson, 2013) to protect the infant and the 
mother. Antenatal depression describes the occurrence of depressive symptoms during 
pregnancy (Cohen et al., 2010) and occurs in about 10% of pregnant women (Mukherjee, 
Trepka, Pierre-Victor, Bahelah, & Avent, 2016). Some symptoms of antenatal depression may 
resolve during pregnancy, soon after childbirth, or could increase the risk for depression 
following childbirth.  
Postpartum depression (PPD), the most common label used to describe depression in 
women after childbirth, is often used interchangeably with labels such as “maternal depression” 
and “perinatal depression” (though perinatal depression can encompass both antenatal and 
postnatal depressive disorders). PPD is characterized as a depressive period during which a range 
of symptoms appear at any time during the first year following childbirth. In a past reference 
manual, the Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revised 
(APA, 2000), the American Psychiatric Association (APA) used the term PPD to refer to 
depressive symptoms occurring after childbirth; however, the current Diagnostic and Statistical 
Manual of Mental Disorders, 5th edition (DSM 5; APA, 2013) now refers to PPD as peripartum 
major depressive episode. The DSM 5 does not recognize peripartum depression as a distinct 
disorder with a specific code but considers it a clinical Specifier of Depressive Disorders. The 
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DSM 5 (APA, 2013) stipulates the onset of peripartum depression must occur during pregnancy 
or within the first four weeks of childbirth.  
Table 1, adapted from Guille et al., provides an overview of MDD and how those 
symptoms manifest as PPD and distinguishes between expected stressors of new motherhood and 
clinically relevant concerns. Symptomatic manifestations of PPD (see Table 1) can include 
excessive sadness, tearfulness, increased anxiety, guilt, difficulty concentrating, sleep 
disturbances, loss of interest in previously enjoyable activities, as well as suicidal ideation (Patel, 
Bailey, Jabeen, Ali, & Barker, 2012). According to the DSM 5, severity of MDD/peripartum 
symptoms can range from moderate to severe, the definitions of which are unclear but are 
presumably determined using clinical judgment, and are considerably worse than the mild, brief 
depressive symptoms of the “baby blues” (Cohen et al., 2010).  
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Table 1. Consideration for the Diagnosis of Major Depression with Postpartum Onset Adapted 
from Guille, Newman, Fryml, Lifton, & Epperson (2013) 
DSM 5 Diagnosis of Major 
Depression (5 or more 
symptoms) with at least 1 
being #1 or #2, present for 
most of the day, nearly 
every day for at least 2 
weeks 
Occurrence in the 
postpartum period 
Suggestive of Postpartum 
Depression 
1) Depressed mood 
Common in “baby blues”; 
typically peaks 4 to 5 days 
after birth, may last hours to 
days and resolve by 2 weeks 
Sad or depressed mood that 
persists daily for at least 2 
weeks. 
2) Lack of pleasure or 
interest in activities  
Uncommon after childbirth 
Inability to derive pleasure 
from experiences or lack of 
interest in things that are 
normally enjoyable. 
3) Sleep disturbance  
Common due to newborn 
care 
Inability to rest or sleep when 
newborn is sleeping or 
inability to care for newborn 
because of hypersomnia. 
 
4) Loss of energy 
Common due to sleep 
deprivation 
Continues despite adequate 
sleep or napping 
5) Agitation or 
retardation 
Uncommon after childbirth 
Moving or speaking so 
slowly that others have 
noticed or being so fidgety or 
restless that one is unable to 
sit still.  
6) Excessive feelings of 
guilt or worthlessness 
Uncommon after childbirth 
Feeling badly about oneself, 
feeling like a failure, or 
having let self or family 
down 
 
7) Diminished 
concentration or 
indecisiveness 
Common due to sleep 
deprivation 
Frequently losing train of 
thought or inability to make 
decisions 
8) Frequent thoughts of 
death or suicide 
Uncommon after childbirth 
Thoughts of “I wish I would 
not wake up” or “my baby 
would be better off without 
me” or intent, desire or plans 
to end one’s life. 
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The wide-ranging terms used to measure and describe depression in women after 
childbirth create a challenge when attempting to integrate findings. Though the DSM 5 now 
refers to PPD as peripartum depression, this paper will employ the term PPD to mean either a 
single episode of major depression or major depressive disorder occurring during the first year 
following childbirth (Gaynes et al., 2005), since this is generally the most common definition, 
and a more stringent operational definition is not relevant for this study, since this study 
addresses clinical impairment and distress related to depressive symptoms following childbirth, 
regardless of a precise diagnosis. 
PPD Symptom Trajectory 
A longitudinal study conducted by Horowitz and Goodman (2004) assessed mothers for 2 
years following childbirth and found PPD to peak around 4-8 weeks postpartum, decreasing over 
time with notable significant mean change in scores from 4-8 weeks to 10-14 weeks and no 
significant mean changes from weeks 10-14 to 14-18 weeks.  Additionally, mothers who 
reported persistent PPD at 10-14 weeks continued to experience symptoms for at least 2 years 
following childbirth, at which time the study ended and further assessment of symptoms ceased 
(Horowitz & Goodman, 2004). These results suggest two pathways: 1) those whose symptoms 
peak early and improve in the first three months after childbirth, and 2) those whose symptoms 
increase during the first three months and remain stable over a longer period of time. 
Etiology and Risk Factors 
To date, research shows a myriad of biological, genetic, psychological and social risk 
factors can place mothers at a higher risk of experiencing PPD, with compounding risk as the 
number of risk factors increases. Biological factors for PPD include poor physical health (Sword 
et al., 2011), higher body weight, and having a negative body image (Green, Broome, & 
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Mirabella, 2006). Couto and colleagues (2015) assert genetics (e.g., 5HTT, TPH, OXTR genes) 
may play a pivotal role in the development of PPD, and depression in general, as discussed in 
their recent systematic review of the literature.  
The list of psychological risk factors is lengthy and includes a history of antenatal 
depression (Lee, Lam, Sze Mun Lau, Chong, Fong, 2007), anxiety, as well as a previous history 
of other psychiatric illnesses (e.g., depression, bipolar disorder; APA, 2013) and substance abuse 
(Rich-Edwards et al., 2006). Additional psychosocial risk factors include poor marital 
relationship, stressful life events (Escriba-Aguir & Artazcoz, 2011), childcare stress (Leung, 
Martinson, & Arthur, 2005), a negative attitude toward pregnancy (Kitamura et al., 2006), poor 
quality of life (de Tychey et al., 2005), and a perceived high level of stress (Wang & Chen, 
2006).  
Socio-demographic factors predicting PPD include young maternal age (Sword et al., 
2011), low education level (Chien et al., 2006), low income (Eastwood, Jalaludin, Kemp, Phung, 
Barnett, 2012), and unemployment (Rubertsson, Wickberg, Gustavsson, Rådestad, 2005). One of 
the most significant predictors of PPD is the lack of social support from family and friends 
(Gaillard, LeStra, Mandelbrot, Keïta, Dubertret, 2014). Studies of risk factors that have rendered 
inconclusive findings of their contribution to PPD include unplanned pregnancies, sex of child, 
mode of delivery, and the non-initiation of breast-feeding (Norhayati et al., 2015). The numerous 
of biological, psychological, and genetic variables related to PPD onset and severity makes the 
task to prevent or lessen symptoms as well as treat the underlying cause an uphill battle, 
especially when it comes to a starting point in care.  
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Impact of PPD on Mothers and their Children 
If left untreated PPD can have short- and long-term deleterious effects on the mother and 
the child. PPD can increase a mother’s risk for future psychiatric illnesses and substance abuse 
and decrease her adaptive functioning (Norhayati et al., 2015). The impact of PPD can also 
extend to poorer family functioning (e.g., increased arguments with spouse, disrupted daily 
routines) and work productivity (Beck, 2001; Stewart, Ricci, Chee, Hahn, & Morganstien, 2003).  
Mothers with PPD are less emotionally and physically able to care for their child 
(Kingston, Tough, & Whitfield, 2012). From a pediatric perspective, research shows PPD can 
distract from pediatric safety practices such as securing a child’s car seat or bringing a child to 
their Well Child Check visits (WCC; Mandl, Tronick, Brennan, Alpert, & Homer, 1999), and 
may contribute to decreased rates of breastfeeding (McLennan & Kotelchuck, 2000) and poorer 
response to their child’s hunger signs and boredom (Beck, 1995). Moreover, families with at 
least one parent coping with depression are also more likely to over-utilize pediatric acute 
healthcare services in young ages (Sills, Shetterly, Xu, Magid, & Kempe, 2007). 
One hypothesized mechanism through which PPD can have negative consequences on 
child development is poor attachment or infant-mother bonding. Mother-child dyads with a 
healthier and secure attachment predict appropriate emotional development in children 
(Onunaku, 2005), whereas mothers who are depressed are more likely to develop less secure 
attachments with their children, which can result in poorer emotional development within the 
child (Beck, 1995). This lack of attachment can function as a negative feedback loop, resulting in 
a child with a lowered interest in interacting with his/her mother and impeding a mother’s 
attempts to develop intimacy with her child, thereby resulting in a cyclical pattern of depression 
in the mother later in life.  
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Negative effects of PPD can extend from infancy into important early childhood 
domains, such as developmental, behavioral, emotional, and physiological functioning. 
Developmentally, if mothers do not spend an adequate amount of quality time with their child 
then language acquisition may be delayed (NICHD, 1999). Children of mothers who had PPD 
are more likely to exhibit behavioral disturbances in later toddler and early childhood years 
(NIHCM, 2010), and having a parent with depression, PPD or otherwise, is also a risk factor for 
the onset and persistence of major depressive episodes in adulthood (Lara & Klien, 1999). 
Children of mothers who had PPD is correlated to stress placed on the hypothalamic-pituitary-
adrenal system which results in increased levels of cortisol. Increased levels of cortisol impact 
one’s ability to appropriately adapt behaviorally to future stress; therefore, chronic 
environmental stress early in life, such as maternal depression, during critical brain development 
periods. This can negatively impact a child’s physiology, placing them at a higher risk for 
internalizing disorders, such as anxiety, social wariness, withdrawal, and externalizing and 
disruptive behaviors (Essex, Klein, Cho, & Kalin, 2002).  
Not only can PPD impact psychosocial functioning of the mother-child dyad and family, 
PPD can be a monetarily costly illness and contributes to the overall high treatment cost of 
depression in the United States. The exact economic burden of PPD is unknown since there are 
no reliable mechanisms to evaluate specific burdens; however, in 2000 it was estimated that 
general depression was responsible for $26.1 billion dollars in direct medical costs, $5.4 billion 
in suicide-related mortality costs, and $51.1 billion in workplace costs (NICHM, 2010). 
Furthermore, these numbers do not appear to include pediatric costs of frequent acute and 
emergency pediatric visits (Sills et al., 2007), and more developmental and behavioral issues 
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requiring treatment (Essex, Klein, Cho, & Kalin, 2002; NICHD, 1999), which could contribute 
to a higher economic burden on the family as well as the healthcare system.  
Treatment Options 
If more moderate or severe symptoms are left untreated, PPD is unlikely to remit (O’Hara 
& Swain, 1996) and symptoms continue to impact maternal, child and family functioning. 
Fortunately, there is evidence to suggest PPD can be treated successfully. Effective treatments 
for PPD include psychotherapy and psychopharmacology, and the National Institute for Health 
Care Management (2010) offers an outline for recommended PPD treatment modality according 
to reproductive status. Intuitively, the earlier treatment begins, such as when symptoms first 
emerge and during infancy of the child, the more opportunity for reduced risk in the mother and 
child (Essex et al., 2002).  
Psychotherapy is often the first line treatment for mild to moderate depression (Freeman, 
Joffe, & Cohen, 2012), and it is well-documented that mothers typically prefer psychotherapy 
instead of medication, as mothers are often concerned of exposing their newborn to medication 
via breastfeeding (Dennis & Chung-Lee, 2006; Pearlstein et al., 2006). Peer support and 
interpersonal therapy (IPT) are two researched modalities of treatment that have demonstrated 
moderate reductions in symptoms in patients when compared with treatment as usual groups. 
A multisite randomized controlled trial (Dennis et al., 2009) found peer support telephone 
calls (mother-to-mother) to be a helpful method in preventing postnatal depression in women 
considered high risk (screening within the “At-Risk” or “Clinically Significant” ranges of the 
Edinburgh Postnatal Depression Scale; EPDS; Cox, Holden, & Sagovsky, 1987). Mothers were 
eligible for the study if they were two weeks postpartum and at least 18 years of age. Mothers 
were then randomized to a control group or an intervention group. The intervention group 
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included access to all standard postpartum care (i.e., services from public health nurses, 
physicians, and various community providers or resources) and a match with a peer volunteer, 
similar in demographic categories, who made at least 4 contacts with the mother, or more as 
desired, with an average of 8 contacts. The control group only had access to those services if 
they were actively sought out by the mother. Nurses blinded to the conditions followed-up with 
mothers at 12 and 24 weeks postpartum and found women in the intervention group were 
significantly less likely than those in the control group to report symptoms of postpartum 
depression (Dennis et al., 2009).  
Another randomized controlled trial found brief (9 sessions) Interpersonal Therapy for 
mothers (IPT-MOMS) was effective at reducing symptoms of depression, as measured by the 
Hamilton Depression Rating Scale, and increasing functioning, as measured by the Global 
Assessment of Functioning, compared to the treatment as usual group (i.e., provided feedback on 
score, psychoeducation, and encouraged to seek treatment) at 3- and 9-month follow-ups (Swartz 
et al., 2008). A similar study found comparable results using Interpersonal Therapy Brief (IPT-B; 
8 sessions) compared with a treatment as usual group (Grote, Swartz, Geibel, Zuckoff, Houck, 
and Frank, 2009). Grote et al. (2009) concluded IPT-B can help to reduce PPD symptoms and 
improve social functioning. Stuart and O’Hara (1995) also found mothers with PPD who were 
randomly assigned to a 12-week manualized IPT treatment, compared to a waitlist condition, 
reported significantly fewer depressive symptoms, as well as significant improvements in their 
relationships with their partners at the end of treatment. 
In a study conducted by Cooper, Murray, Wilson, & Romaniuk (2003) in the United 
Kingdom, short- and long-term maternal mental health outcomes, as measured by the Edinburgh 
Postnatal Depression Scale (Cox et al., 1987), were assessed in 193 mothers at four distinct times 
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(4.5, 9, and 18 months postpartum and 5 years postpartum) across 5 years. Mothers were 
assigned to one of four groups (routine primary care, non-directive counseling, cognitive-
behavioral therapy, psychodynamic therapy). This study found all three treatment groups notably 
improved maternal mood 4.5 months following treatment, but failed to find detectable difference 
in the number of mothers who spontaneously remitted from depression and those who were 
treated soon after giving birth from 9 months to 5 years.   
Acceptance and Commitment Therapy (ACT) is another form of psychotherapy with 
empirical support to treat a range of psychological concerns (Substance Abuse and Mental 
Health Service Administration, 2010). ACT works to alter one’s relationship with internal 
experiences (i.e., unhelpful thoughts, physiological sensations) to strengthen value-directed 
action (Hayes, Strosahl, & Wilson, 1999). ACT has been shown to reduce depressive symptoms 
in adults. Bohlmeijer, Fledderus, Rokx, and Pieterse (2011) conducted a study in which 49 
participants were assigned to receive ACT for two hour sessions for eight weeks, and 44 
participants were assigned to a waitlist control. The average depression score among those who 
received the ACT intervention was below cut-off and significantly lower than the waitlist 
controls immediately following treatment and three months following treatment.  
 Focused Commitment and Acceptance Therapy (FACT), a briefer form of ACT, 
designed for use in primary care settings, improves access to effective and short-term treatments. 
One study found FACT was just as effective at Solution-Focused therapy but yielded fewer 
dropouts (Strosahl, Hayes, Bergan, and Romano, 1998); however, more research is needed to 
support and examine the utility of FACT in primary care settings.   
For mothers experiencing moderate to severe PPD, and/or who have comorbid 
symptoms, such as anxiety, or are unresponsive to therapy, antidepressants are often a 
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recommended and appropriate treatment starting point. Significant improvements in depressive 
symptoms are well-documented for mothers using antidepressants, including fluoxetine (Prozac), 
sertraline (Zoloft), nortriptyline (Palemor), paroxetine (Paxil), venlafaxine (Effexor), 
fluvoxamine (Luvox), and bupropion SR (Wellbutrin SR; Guille et al., 2013).  
According to Dietrich and colleagues (2003), patients receiving either psychotherapy or 
antidepressants usually begin to see an improvement in symptoms within 6 to 8 weeks. However, 
if an antidepressant is the chosen method of treatment it is suggested that patients with a first-
time diagnosis of depression should continue pharmacological treatment for 9 to 12 months after 
depression symptoms have abated (Logsdon, Wisner, Billing, & Shanahan, 2006).  Although 
research suggests no immediate short-term negative effects to the child, little is known regarding 
long-term effects on the child’s brain or nervous system development (Thurgood, Avery, & 
Williamson, 2009), which may also explain why some mothers wish to forego 
psychopharmacological treatment if they are breastfeeding. 
 Some research has also demonstrated the treatment of depression, in general, to be 
effective at mitigating negative outcomes in children (Pilowsky et al., 2008), while other studies 
suggest improvement in outcomes for the mother may not translate to improved short- and long-
term child outcomes. Pilowsky et al. (2014) conducted a randomized study in which mothers and 
fathers were assigned to one of three treatment groups: bupropion (Welbutrin); escitalopram 
(Lexapro); or both. The study examined whether parents treated for depression improved child 
outcomes, as measured by rates of anxiety, using the Multidimensional Anxiety Scale for 
Children (March, 2013), depression, using the Children’s Depression Inventory (Kovacs, 2011), 
and overall functioning (e.g., Columbia Impairment Scale; Bird, Shaffer, Fisher, & Gould, 1993, 
Child Global Assessment Scale; Shaffer et al., 1983) scales for children. Interestingly, results 
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suggest children function better with depressed fathers at baseline but yield more functional 
improvement when their mothers are treated for depression. However, a limitation of this study 
was the few number of fathers (n = 9) compared to the number of mothers (n = 34). 
Another large-scale study was conducted in the United States by Forman et al. (2007) 
comparing mothers with PPD randomly assigned to IPT or a waitlist, to a non-depressed 
comparison group. Mother’s in the IPT treatment group reported improved perceptions of stress 
compared to the waitlist control but their levels of stress perception did not decrease to the level 
of the non-depressed control group. Although mothers’ perceptions of stress improved, the 
treatment group reported no significant improvements in child outcomes 18 months later, rating 
their children as low in attachment security, high in behavioral concerns, and more negative in 
temperament than non-depressed mothers.   
Preliminary results are encouraging. Treatment appears to improve mother and child’s 
psycho-social outcome. Cooper et al. and Forman et al. recommend future development of 
treatments should include a focus on the mother-child dyad instead of improvements for the 
mother alone. Indeed, Milgrom and Holt (2014) have proposed a randomized controlled trial to 
test an intervention designed to target the mother-infant dyad in mothers experiencing postnatal 
depression. This study has yet to be published.  
Despite the existence of efficacious interventions to treat mothers and improve their 
outcomes, many mothers are untreated due to a variety of personal and systemic barriers 
(NIHCM, 2010). For example, some mothers might be concerned about social stigma 
surrounding depression following childbirth (Koniak-Griffin, Logsdon, Hines-Martin, & Turner, 
2006), whereas others may have concerns about the cost of treatment or insurance coverage. A 
lack of knowledge about the impact of depression on personal and familial health may also 
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contribute to low treatment rates (NIHCM, 2008). Some mothers may be less likely to mention 
their symptoms to their child’s pediatrician fearing their provider may judge or report them to 
child protective services (Heneghan, Mercer, & DeLeone, 2004). Lastly, many mothers may be 
unaware of the psychoeducation related to PDD or local treatment resources and may lack access 
to childcare if they decide to seek treatment (Gjerdingen, Katon, & Rich, 2008).  
Many pediatricians are admittedly hesitant to approach mother about PPD concerns, 
which further compounds the burden of mother’s perceptions that others would judge their 
internal experience. For example, one study found approximately 2 out of 5 pediatricians 
believed it was not in their job description to detect PPD in new mothers. Providers, both 
OB/GYN and pediatricians, also reported having a low level of confidence in accurately 
detecting and managing symptoms of depression in their patients’ mothers (Olson et al., 2002). 
Further, providers indicate they lack the time to address mothers’ mental health issues since the 
child’s health is at the forefront of the visit (NIHCM, 2010). Other workforce barriers such as a 
shortage of mental health providers, especially in rural areas, may discourage primary care 
providers from asking mothers about their feelings and providing a referral if there are few 
community resources to address their concerns (McCue Horwitz et al., 2007; Wiley, Burke, Gill, 
& Law, 2004).  
Detection of PPD 
To eliminate the many barriers hindering the connection of treatment of PPD, several 
agencies, including the United States Preventative Services Task Forces (USPSTF, 2009; 
Pignone et al., 2002) and the Bright Futures organization, closely partnered with the American 
Academy of Pediatrics (AAP), have made detection of PPD a top priority and developed 
recommendations for providers to follow. For example, the USPSTF advocates for screening all 
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mothers for PPD in the first few WCC and recommends medical practices create individualized 
systems to ensure screening, treatment, and follow-up for mothers occurs. 
A recent update of the USPSTF Recommendations Statement, entitled “Screening for 
Depression in Adults” (2016), endorsed screening as an effective method for improving 
detection of depression in adults and listed antidepressants, psychotherapy, and combination 
treatments as effective in decreasing morbidity and improving clinical outcomes. It is also 
considered appropriate to recommend psychotherapy over medication to women who are 
pregnant or breastfeeding. The USPSTF grades their own recommendation as “B,” with the 
operational definition of the “B” grade being: “The USPSTF recommends the service. There is 
high certainty that the net benefit is moderate, or there is moderate certainty that the net benefit is 
moderate to substantial.” (p. 381, USPSTF, 2016).  
However, the USPSTF and AAP offer little in terms of empirically-supported methods 
for reliably achieving acceptable levels of screening and follow-up services and leaves the 
execution of these recommendations up to the individual practice. The paucity of methods is due, 
in part, to the widely variable resource and assistance availability and procedures of medical 
practices. Indeed, it would be challenging to suggest a universal screening and follow-up 
procedure that fits the needs of every practice.  
Further, the USPSTF acknowledges their limitations in being unable to consider cost, 
policy, and coverage in their recommendations (USPSTF, 2016). The previous recommendations 
(2009) included the caveat that screening and management of depression in adults in primary 
care settings were only to be conducted if there were “staff-assisted” care supports in place; 
however, the USPSTF (2016) has adjusted to the evolving nature of collaborative healthcare and 
recognizes care supports are becoming more common and have now eliminated that caveat to the 
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recommendations. The content most pertinent to this study is the inclusion to specifically 
encourage screening for postpartum depression (USPSTF, 2016). 
Pediatricians have a unique advantage to screening new mothers for PPD. As a result of 
treating the child, pediatricians see new mothers more frequently than the mothers’ own primary 
care provider and/or their obstetrician and gynecologist (Chaudron, Szilagyi, Kitzman, Wadkins, 
& Conwell, 2004). The AAP strongly encourages families, which are typically biological 
mothers, to bring their child to 6 scheduled WCC’s within the first 6 months of a child’s life (2 
days, 1 week, 1 month, 2 months, 4 months, 6 months). In addition, the pediatric primary care 
provider has a unique relationship with families providing continuity of care throughout the 
child’s formative years. This care focuses not only on the child but also on how parental health 
and family dynamics contribute to child health and well-being (Earls, 2010). Although the 
identified patient remains the child, considering family functioning as it affects the child is 
within scope of practice for pediatricians, who are in a prime position to provide family support 
and referrals to resources that directly or indirectly enhance a child’s functioning and 
development (Earls, 2010).   
To prepare pediatricians to effectively broach and address PPD, Bright Futures and the 
AAP suggest pediatricians use one of two methods to identify at-risk mothers, which, seemingly, 
offers a specific recommendation that the USPSTF does not offer. The first method is a validated 
two-question screener that can be administered orally (i.e., “Over the past two week have you 
ever felt down, depressed, or hopeless?” and “Over the past two weeks have you ever felt little 
interest of pleasure in doing things?”). The second method is using the 10-item Edinburgh 
Postnatal Depression Scale (EPDS, Cox et al., 1987), the most widely used screener in clinical 
practice for PPD assessment (Gaynes et al., 2005; Norhayati et al., 2015), especially in primary 
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care settings (Olin et al., 2016). Items on the EPDS assess more facets of depressive symptoms 
(e.g., anxiety, difficulty sleeping, suicidal ideation) and its short length, simple scoring 
procedure, and zero cost make it an ideal instrument to use in busy and financially-strapped 
pediatric settings (Cox et al., 1987). The AAP encourages the use of a screening mechanism at 1-
, 2-, 4- and 6-month WCC visits, when symptoms are most likely to emerge and peak (Earls, 
2010; Horowitz & Goodman, 2004) and to utilize the Current Procedural Terminology (CPT) 
code 99420 to bill for the risk assessment instrument.  
Feasibility of Screening 
In a meta-analysis by Pignone et al. (2002), PPD screening practices significantly 
improved detection rates of PPD from 10% to 49%, regardless of screening measure (e.g., EPDS,  
Cox et al., 1987; Center for Epidemiological Study Depression Scale; Radloff, 1977, Self-
Depression Scale; Zung, 1965, Beck Depression Inventory; Beck, Steer, Brown, 1996, Hamilton 
Depression Scale; Hamilton, 1967). Though screening practices are intended to assess 100% of 
individuals considered high risk for a condition (target population), research suggests efforts to 
screen every mother at all the recommended WCC’s falls short of capturing data on everyone in 
the intended target population. Chaudron et al. conducted a study examining the feasibility of 
incorporating the EPDS as part of a universal screening protocol for mothers of children aged 0 
to 1 year, in a pediatric primary care clinic. This was a pre- and post-design study in which 110 
infant charts were randomly selected and reviewed prior to the universal screening protocol and 
110 charts were reviewed after the protocol implementation to examine differences in detection 
rates of depression. Results indicated that of 223 child visits, 46% (N = 102) of the post-
intervention visits included an EPDS. Chaudron et al. noted a significant increase in screening, 
detection (up from 1.6% in cohort 1 to 8.6% in cohort 2), and referrals to social work (up from 
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0.2% in cohort 1 to 3.5% in cohort 2) from the previous year but failed to assess every mother 
eligible. Arguably, there is room for procedural improvement to ensure every mother is screened. 
This study lacked a description or recommendations regarding how to appropriately train 
pediatric office personnel to ensure all mothers are screened. 
Freeman et al. also conducted a study designed to examine the feasibility of assessing 
mothers at their child’s WCC with slightly better results. All mothers attending their child’s 2-
month visit were asked if they would be willing to complete the EPDS. One-hundred seventy-
two women were approached and 89 agreed to participate, yielding a screening rate of 51.7%. 
Both studies yielded modest screening adoption rates, 46% and 51%, respectively, (Chaudron et 
al., 2004; Freeman et al., 2005).  
Possible explanations for screening rates of approximately 50% rather than 100%, as 
discussed by Chaudron et al. and Freeman et al., may include clerical error, such as a misplaced 
instrument, a mother’s refusal to complete the questionnaire due to length or privacy concerns, 
and the presence of a father, grandparent, or foster parent instead of their mother. One study 
(Freeman et al., 2005) gave mothers the option to complete the EPDS instead of incorporating it 
into the routine paperwork, and this choice may have allowed more mothers to decline more 
readily than if it was included in routine paperwork.  
Maternal satisfaction with the screener is another important consideration in the 
feasibility and sustainability of PPD screening practices. In focus group interviews with 27 
postpartum women with self-reported emotional complications (e.g., anxiety, depression), 
barriers and facilitators to maternal postpartum care by their child’s pediatrician were assessed 
(Byatt, Beibel, Friedman, Debordes-Jackson, & Ziedonis, 2013). A majority of mothers felt it 
was within the realm of the pediatrician’s responsibility to assess the well-being of the mother as 
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well as the child, and several mothers suggested the pediatric office was the ideal location to 
address PPD. Further, mothers indicated that psychoeducation about the unique stressors of new 
motherhood was helpful, and that they felt greatly validated and cared for when the pediatrician 
provided the appropriate referral when symptoms of depression were disclosed. It is relevant to 
note that a minority of mothers felt it was not appropriate for their child’s pediatrician to inquire 
or provide guidance on their mental health (Byatt et al., 2013). This small subset of mothers 
could perhaps explain why some children did not have depression screener notations in their 
chart in the studies conducted by Chaudron et al. and Freeman et al. 
Follow-up Services 
Despite commendable screening and detection efforts among at least some pediatric 
practices, the extant literature suggests that even with an accurate diagnosis, many mothers may 
not receive appropriate treatment (Horowitz & Cousins, 2006). Screening practices, ethically, 
must be accompanied by a system to ensure effective referral, treatment, and follow-up 
procedures (Gjerdingen & Yawn, 2008). Essentially, if a concern is detected, it must be 
addressed responsibly. Results on whether screening practices increase referral, treatment and 
maternal outcome rates are mixed, and it can be challenging to draw conclusions about 
screening, referral and treatment practices when methods to do so and measurement of the 
referral and/or follow-up process vary notably across studies. 
Yawn et al. (2012) conducted an evaluation of the screening, diagnosis and management 
of eight PPD screening programs. Again, as previously discussed, their results indicated that 
screening rates varied between 33% and 95%. Fortunately, screening occurs in most primary 
care practices or pediatric practices; unfortunately, some programs did not include a follow-up or 
management plan for those screening as high risk, and the symptom severity evaluative 
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processes were not consistent across settings. Only half of the programs reported on maternal 
outcomes and only two of those reported positive maternal outcomes.  
Yawn et al. argued screening for PPD in primary care is a feasible and appropriate 
practice with the potential to improve maternal outcome 6 to 12 months following childbirth 
when barriers are eliminated. Yawn et al. postulate facilitators (i.e., variables that promote 
success) within the two sites yielding positive maternal outcomes, specifically improved 
screening scores, included trained nurses in brief therapeutic techniques (e.g., motivational 
interviewing, suicide risk assessment) to be delivered immediately and within the setting in 
which the screening occurred.  Further, the authors suggest additional evaluative and 
dissemination studies are needed to confirm feasibility and positive outcomes.  
The research is scarce on what follow-up for mothers presenting and reporting symptoms 
of PPD in pediatric offices looks like and whether or not initiating follow-up care occurs.  Yawn 
et al. and Olin et al.  assert the current literature also lacks studies discussing the feasibility of 
incorporating behavioral health services within a pediatric primary care clinic for mothers, 
despite intuitive knowledge that offering behavioral health services within a pediatric office 
could directly combat barriers related to follow-through (e.g., transportation, times, stigma). Olin 
et al. reviewed several studies of primary care PPD screening practices occurring within a 
primary care setting, with emphasis on pediatric primary care settings. Reports on outcome 
results were not necessarily a priority of the review, though some studies reported on that 
domain. Similar to Yawn et al. (2012), Olin et al. found PPD screening in a primary care setting 
is a feasible method and presented the most common methods of follow-up care. In terms of 
implementation, they found referrals, followed up by staffing (most often by nurses, not 
necessarily mental health professionals), were the most common strategies for support. Olin et al. 
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emphasized that though some studies included referring mothers for medication management to 
treat symptoms. Olin et al. did not find any studies that reliably incorporated a brief in-session, 
or referral to, psychotherapeutic treatment in the PPD program; this is especially salient since 
mothers tend to prefer therapy over medication to treat depression symptoms.  
Though research shows screeners are effective instruments for detecting PPD and are 
feasible to implement is primary care practices (Cox et al., 1987: Downie et al., 2003; Schaper, 
Rooney, Kay, & Silva, 1994; Yawn et al., 2012), only half of all mothers are administered 
screening measures during their child’s WCC (Chaudron et al., 2004; Freeman et al., 2005). 
Moreover, detection as a stand-alone intervention provides little in the way of relief for mothers 
and the literature and agency guidelines are sparse in terms of recommendations and outcomes 
for follow-up care for mother’s reporting symptoms of depression at their child’s WCC.  
Stepped Care Model for PPD 
To address the question of how to ethically and thoughtfully proceed if a mother endorses 
PPD symptoms, Gjerdingen and Yawn (2007) attempted to provide primary care providers (e.g., 
general practitioners, pediatricians) with a comprehensive method of care that included screening 
and follow-through for mothers scoring high on a measure of PPD. Gjerdingen and Yawn (2007) 
assert that starting with a collaborative relationship between medical and mental health care 
professionals can not only yield a more reliable screening procedure but can put mothers into 
contact with meaningful treatments and follow-up care; stating that a stepped care method for 
PPD would work best within an existing multidisciplinary clinic that includes a pediatrician, a 
case manager, a social worker, and mental health service provider. Increasingly, evidence-based 
research supports the application of stepped care protocols and collaborative care for mental 
health concerns (Araya et al., 2003; Patel et al., 2010). 
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Gjerdingen et al. conducted a thorough review of various components of PPD 
management literature (e.g., identification, diagnosing, and initial treatment) and constructed a 
set of best practice recommendations, which emphasized collaborative efforts among health 
professionals from screening through follow up care. The authors proposed a “stepped care 
intervention model,” which is conceptualized as a cost-effective and efficient method of 
managing an illness or condition to “benefit both the provider and the patient” (Gjerdingen et al., 
2008, p. 47). In a stepped care protocol, resources for treatment are allocated based on the 
patient’s needs with more resources being directed to those with more complex and severe 
symptoms (Peterson, Lund, & Stein, 2011), and when initial interventions are deemed 
insufficient, more intensive interventions and follow-up may be applied.  
Gjerdingen et al. suggest that in order for a stepped care protocol to be effective for PPD, 
immediate access to an on-site mental health professional is critical. Quick access to a behavioral 
health professional also functions to eliminate practical barriers that frequently impede mental 
healthcare delivery generally, such as transportation and time. With this type of arrangement, 
pediatricians would also have access to an on-site mental health professional with whom they 
could engage in brief consultation about how to best proceed with patient care, concurrent with 
the patient’s visit. This advantage is especially salient for patients with at-risk backgrounds, such 
as low-income or impoverished families, in which the use of a private vehicle and time spent 
away from family and work is often impractical.  
Current Gap in PPD Treatment Literature 
Research findings have shown: 1) screening for PPD has not been deployed reliably due 
to systemic barriers (e.g., stigma, time), 2) mothers are not offered follow-up treatments such 
pharmacotherapy and psychotherapy (often their preferred method of treatment), and 3) a 
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proposed, but not studied, stepped care model may work to feasibly detect and treat PPD in a 
primary care setting. The purpose of this study to evaluate the coordination of these empirically-
informed methods as a cohesive package (i.e., the stepped care protocol) implemented in a real-
world setting. Additionally, this study will hopefully contribute to a broader research movement 
to accelerate the pace with which research is conducted, analyzed, and utilized to inform 
treatment within primary care (deGruy et al., 2015), to shrink the gap between research and 
application in real-world settings.  
Specifically, this study evaluates the implementation outcomes of one practice’s use of a 
stepped model of PPD (Gjerdingen et al., 2008) including routine screening and a range of best-
practice responses to high scores, including psychosocial treatment, which has yet to be 
examined in the literature (Olin et al., 2016). This study also aims to serve as a replication study 
for the screening portion of this protocol. Finally, this study describes the functions behavioral 
health consultants serve as members of a pediatric healthcare team. The RE-AIM model, a well-
established model from the Dissemination and Implementation Science (D&I Science) field 
(Brownson, Colditz, & Proctor, 2012), was the scaffolding used to format the hypotheses for this 
project and present outcomes. 
RE-AIM Model 
D&I Science aims to identify best practice models and methods for translating efficacious 
treatments into real world settings (Brownson, Colditz, & Proctor, 2012). The RE-AIM model, 
specifically, is a D&I Science method used to evaluate implementation programs such as a 
stepped care protocol for PPD. Developed by Glassgow, Vogt, and Boles (1999), RE-AIM 
evaluates real-world internal and external validity of public health and health behavior 
interventions in a way that meaningfully contributes to a generalizable body of knowledge. This 
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model has the flexibility to be applied to diverse settings (Glasgow, Vogt, & Boles, 1999) and 
could provide a solution to the lack of evaluative cohesion across PPD programs as the Yawn et 
al. (2012) review noted. 
RE-AIM stands for reach, effectiveness, adoption, implementation, and maintenance, 
which the model’s developers claim are markers of suitable and sustainable interventions 
(Glasgow, Vogt, & Boles, 1999; see Table 2). This study will utilize all domains of the RE-AIM 
model; any modification of the model for study purposes is acceptable to accommodate the 
uniqueness of each clinical practice, as long as domains are clearly conceptualized (Kessler et 
al., 2012).  
Table 2. RE-AIM Model Domains Adapted from Glasgow, Vogt, & Boles (1999) 
Domain Definitions 
Reach 
“proportion of the target intervention that 
participated in the intervention” 
Effectiveness 
“success rate if implemented as in guidelines; 
defined as positive outcomes minus negative 
outcomes” 
Adoption 
“proportion of settings, practices, and plans 
that will adopt this intervention” 
Implementation 
“extent to which the intervention is 
implemented as intended in the real world” 
Maintenance 
“extent to which a program is sustained over 
time” 
 
 
 
 
Hypotheses 
The overall aim of this project was to evaluate the real-world employment of a stepped 
care protocol, as delivered by a multidisciplinary healthcare team (i.e., pediatricians, nurses, 
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front-desk administrators, social workers, and an on-site behavioral health consultant), to 
effectively screen new mothers for PPD and provide follow-up care, which included brief 
psychosocial interventions. The specific aims and hypotheses are outlines using the RE-AIM 
domains, which are listed as follows and detailed in Table 3: 
1. Reach is the willingness of participants to engage in the intervention; however, mothers were 
not given a choice to participate in the protocol (i.e., each mother was automatically handed 
the screening instrument at their child’s well child check), as they were within the Freeman et 
al. (2005) study. Therefore, “willingness” per se, was not able to be assessed. Reach was 
defined as the percentage of screeners completed and recorded for all types of WCC (1 week, 
1 month, 2 month, 4 month, and 6 month) within one year. This approach to reach has been 
used in previous research (e.g., Belkora, 2015). The second way in which reach was 
measured, was by capturing the percentage of WCC in which a positive screening score was 
detected (i.e., within the screening instrument’s “At-Risk” or “Clinically Significant;” score 
of > 9). This facet of the reach domain is particularly important since mothers with positive 
screens are the specific target of this protocol and helped identify the prevalence of PPD 
among the families served within this particular clinic. Finally, reach also measured whether 
or not mothers screening positive came into contact with one of the interventions listed in the 
menu of options (e.g., psychoeducation, onsite BHC visit, follow-up phone call, outside 
mental health referral).  
Hypotheses:  
a) The implementation of the stepped care protocol, as adapted from Gjerdingen 
et al., will result in a higher screening rate (i.e., the screen will reach more 
patients) than previous research, which showed a reach rate of approximately 
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50% (Chaudron et al., 2004; Freeman et al., 2005) given the use of D&I 
Science to inform the intervention. In other words, a majority of WCC notes 
for children aged 0 to 6 months will receive an EPDS screener, as evidenced 
by documentation within the child’s WCC note.  
b) Based on previous research it is anticipated that approximately 10% to 20% of 
EPDS scores recorded in visit notes will yield a positive screen (i.e., “At-
Risk” or “Clinically Significant”; NIHCM, 2010). 
c) It is hypothesized that a majority of mothers screening positively on the EPDS 
will come into contact with Step 3 (i.e., psychoeducation, brief intervention, 
and/or EPDS) and/or Step 4 (one-week follow-up phone call) of the stepped 
care protocol (see Figure 1).  
2. Effectiveness is defined as the impact on an intervention’s targeted outcome. This study 
measured effectiveness using a multiple regression analysis to examine the relationship 
between an early depression score, collected at either 1 or 2 months (if a child was not seen 
for their 1-month, then the child’s 2-month WCC was used), when symptoms tend to emerge 
and peak (Horowitz and Goodman, 2004) and a mother’s final EPDS score at 6 months for 
children seen for each visit over the six-month period. Further, the potential moderating role 
of the type of intervention received (i.e., education, onsite BHC visit, BHC phone call 
follow-up), as compared to non-intervention (i.e., No Action) for mothers scoring high at 
their 1- or 2-month visit was examined.  
Hypothesis: 
a) It is hypothesized that mothers scoring within the “At-Risk” or “Clinically 
Significant” range at the 1- or 2-month WCC who received at least one type of 
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intervention from the menu of options at that time will endorse significantly lower 
scores on the screening instruments at the 6-month WCC compared to those mothers 
who did not receive any type of intervention within Step 3 or 4 of the protocol. 
3. Adoption is defined as the percentage of eligible WCC’s (e.g., newborn to 6-month WCC) 
for whom the EPDS score is documented in the EHR by each pediatrician. In this study, 
reach is also directly related to the extent to which the intervention was adopted, which is the 
extent to which (i.e., the percentage of a pediatrician’s WCC’s that have an EPDS score 
documented in the note) absolute number of intervention agents (i.e., pediatricians) willing to 
participate, or carry out, components of the protocol. 
Hypothesis: 
a. A majority of the clinic’s pediatricians will have an EPDS score listed in WCC 
notes, an improvement from the rates reported in Chaudron et al. (2004) and 
Freeman et al. (2005), which were 46% and 51.7%, respectively. 
4. Implementation refers to the intervention agents’ fidelity to all intervention components. To 
evaluate implementation this domain examined the course of care for every mother who 
brought her new child to the Clinic for every scheduled WCC for the first 6 months of the 
child’s life (5 visits total), including screening and follow-up care. This domain will examine 
the pattern of care only for mothers who attended all 5 WCC’s and answer the question: 
“What is the typical care for mothers who screen positive and negative on the EPDS?” This 
hypothesis is operationalized as an assimilation of reach, adoption, and maintenance. 
Hypothesis: 
a. Given the highly collaborative environment of the pediatric primary care clinic 
and the time devoted to develop a D&I Science-guided implementation process, 
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and the use of the Consolidated Framework for Implementation Science to guide 
development and implementation of the protocol, it is hypothesized that the 
stepped care protocol had the supports in place to be implemented as designed for 
all mothers who attended all five WCC. Specifically, mothers who screen within 
the “positive” range will have interventions ordered and receive care (e.g., onsite 
BHC visit, BHC phone call follow-up) as outlined by the stepped-care protocol 
(see Figure 1).   
5. Maintenance is the extent to which an intervention becomes a part of routine practice within 
an organization. Monetary reimbursement is a motivating and contributing component to the 
longevity of an intervention. To evaluate and determine this component of the protocol’s 
sustainability, the total dollar amount the clinic received in reimbursement from the EPDS 
was calculated.  
Hypothesis: 
a) Based on pilot data (Smith, Polaha, Tolliver, & Baker, manuscript in preparation), it 
is hypothesized that the practice will make approximately $15,000 over 12 months, 
since the screening instrument used is reimbursable using the Current Procedural 
Terminology (CPT) code 99420, which is the “administration and interpretation of 
health risk assessment instrument”.  
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Figure 1.  Stepped Care Protocol of Postpartum Depression in a Pediatric Setting 
 
 
 
 
 
 
 
 
 
 
Step 1:
Front desk hands all mothers of 
children 0-6 months of age, at 
every  well child-check up an 
EPDS
Step 3:
Score of 0 - 8: Non-significant
-No action taken
Step 3:
Score of 9 - 12: "At-Risk"
a) psychoeducation about PPD 
provided by pediatrician and/or 
BHC
b) brief intervention provided by 
on-site BHC
Step 4:
-one week follow-up phone call 
is ordered.
Step 3c:
Score of 13 < : "Clinically 
Significant"
a) psychoeducation about PPD 
provided by pediatrician and/or 
BHC
b) brief intervention is provided 
by on-site BHC
c)EPDS is faxed to primary care 
provider or OB/GYN
Step 4:
-one week follow-up phone call is 
ordered.
Step 2:
Pediatrician reviews and scores 
EPDS and documents score in 
EHR. Based on score, one of the 
following actions will occur:
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Table 3. RE-AIM Aims and Hypotheses of the Postpartum Depression Stepped Care Protocol  
1. Aim 1: Evaluating reach by capturing the percentage of visits with a positive score during which an intervention 
(i.e., Step 3 and/or 4) was provided. 
Question Hypotheses 
a) Of all visits between February 25, 2014 and 
September 15, 2015, how many visits have an 
associated EPDS score documented in the visit 
note? 
b) How many EPDS scores yield a positive screen? 
c) Of mothers who screen positively on the EPDS, 
how many came into contact with at least one type 
of intervention from the menu of options (i.e., 
Steps 3 and 4).  
a) The implementation of the stepped care protocol, 
as adapted from the guidelines set forth by 
Gjerdingen, et al., will have a higher screening 
rate than previous research has found of 
approximately 50%(Chaudron et al., 2004; 
Freeman et al., 2005). 
b) Based on previous research, it is anticipated that 
approximately 10% to 20% of EPDS scores 
collected will yield positive EPDS scores 
(NIHCM, 2010) 
c) A high number of mothers will come into contact 
with Step 3 and/or 4 of the stepped care protocol.  
Aim 2: Evaluating effectiveness by examining the relationship between the EPDS scores at 1 or 2 months and the 
score at 6 months, and whether or not the mother’s score at 6 months is moderated by the type of intervention a 
mother received compared to mothers who did not come into contact with an intervention. 
Question Hypothesis 
a) Can 1- or 2-month EPDS score predict 6-month 
EPDS scores? 
b) Is the relationship between 1- or 2-month EPDS 
score moderated by the presence of an intervention 
provided by the pediatric clinic? 
a) Mothers provided at least one type of intervention 
will endorse significantly improved scores at the 6 
month WCC compared to those mothers who did 
not come into contact with an intervention.  
Aim 3: Evaluating the adoption by determining the percentage of eligible WCC that have a documented EPDS 
score by pediatrician 
Question: Hypothesis: 
a) What is the percentage of WCC notes with an 
EPDS score noted categorized by pediatrician? 
a) A majority of the clinic’s pediatricians will have 
an EPDS score listed in over 50% of their WCC 
notes. 
Aim 4: To evaluate implementation by providing an overview of the typical care a mother, screening positively, 
receives. 
Question: Hypothesis: 
a) What is the typical care of a mother who scores 
within the “At-Risk” or “Clinically Significant” 
range of the EPDS? 
a) The stepped care protocol will be implemented as 
designed. 
Aim 5: To evaluate the sustainability and maintenance of the stepped care protocol.  
Question: Hypothesis 
a) In sum, how much did the practice collect in 
reimbursement from the EPDS screener across 12 
months? 
a) Based on preliminary data it is hypothesized the 
practice will make approximately $15,000 over 
one year 
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CHAPTER 2 
METHOD 
Setting and Providers 
This study took place in a university-affiliated Pediatric Clinic (hereafter referred to as 
the Clinic) in the southern Appalachian region of the United States. The site is an established 
training agency for medical students and residents gaining clinical experience under a 
preceptorship model, and other healthcare graduate students (clinical psychology and social 
work) attending the local state university. At the time of this evaluation, the Clinic supported 8 
pediatric faculty preceptors, 19 interns and residents, 8 nurses, and a rotation of medical students 
(typically 4 medical students during any given week throughout the year).  
The Clinic serves children 12 years of age and under seen for routine well child checks 
(WCC), follow-ups, and acute visits, who live within the surrounding region of southern 
Appalachia, including northeastern Tennessee, southwestern Virginia, and northwestern North 
Carolina. Based on conversations with Clinic administrative personnel who manage operations 
and billing, approximately 70% of all patients of the Clinic are covered under various types of 
Medicaid insurance, which is typically held by families living in a lower socio-economic status. 
Approximately 30% of patients hold private health insurance plans. The level of integration 
within the clinic may fall under the category of “Level 5: Close Collaboration Approaching an 
Integrated Practice” model of care to provide team-based care for their patients (SAMHSA-
HRSA, 2013). Based on a flow chart, published by Waxmonsky, Auxier, Romero, and Heath 
(2014) this clinic operates, in part, through frequent communication between multiple providers, 
have regular meeting to discuss overall patient care and specific patient issues, and have in-depth 
understanding of roles and culture. 
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Behavioral Health Consultants 
The Clinic has a five-year history of engaging a collaborative practice model with 
behavioral health.  Specifically, they have incorporated students from a local state university 
clinical psychology doctoral program as the on-site mental health professional, referred to as the 
Behavioral Health Consultant (hereinafter referred to as BHC), to address common pediatric and 
child behavioral, developmental, and psychological issues that often arise in pediatric visits (e.g., 
disruptive behaviors, noncompliance, ADHD, sleep, toileting). A licensed clinical psychologist, 
for the state of Tennessee, supervises the BHC position. It is important to note that there was 
some fluctuation of BHC coverage. At the start of implementation of the protocol, BHC 
coverage spanned approximately 30 hours across two BHC providers; however, 5 months later 
BHC coverage increased to 40 hours per week across 3 providers. Coverage depended on 
available funding for the BHC position, which was provided via external sources.  
The BHC works closely with physicians, nurses, social workers and office staff to deliver 
comprehensive, quality assessments and care by using evidenced-based practices (e.g., warm 
hand-offs, screeners). A similar training arrangement was made for social work master students 
under the supervision of a Licensed Clinical Social Worker for the state of Tennessee to address 
functional needs of the family (e.g., housing, food, respite care). 
A majority of patient referrals to the on-site BHC are conducted through the “warm hand-
off” method. In a warm hand-off, a pediatrician identifies a behavioral or psychological concern 
that arises during a routine WCC or acute visit and then locates the BHC to see the patient during 
the same visit. Other possible patient contact with the BHC occurs through scheduled initial 
appointments and “warm hand-off” follow-up appointments. Additionally, parental, adult and 
family therapeutic strategies are skills needed to be successful in the BHC position. The BHCs 
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providing care to families in the Clinic receive general therapy training across the lifespan and 
are equipped with the skills and resources to address maternal depression.  
Protocol Development: Consolidated Framework for Implementation Research 
The protocol was developed, in part, using the Consolidated Framework for 
Implementation Research model (CFIR; Danschroder, Aron, Keith, Kirsh, Alexander, & Lowery, 
2009) as a guide, which presents a range of recommended constructs to consider when 
developing and individualizing a specific intervention. CFIR is a comprehensive theory designed 
to organize and incorporate constructs of existing implementation science theories into five 
domains of importance: the characteristics of the intervention, inner and outer settings, the 
individuals involved, and the process by which implementation is accomplished. The 
components of an intervention that fall under the domains can be categorized as strengths (i.e., 
facilitators) or weaknesses (i.e., barriers), and the domains interact to influence implementation 
effectiveness (Danschroder, Aron, Keith, Kirsh, Alexander, & Lowery, 2009). The developers of 
the CFIR recognize not every domain is applicable to every setting or intervention and encourage 
researchers to use domains that are relevant to their intervention to allow for individualization.  
Development of Stepped Care Protocol 
Pediatricians at the Clinic often collaborate with the psychology staff on system-wide 
changes oriented toward implementing evidence-based practice or encouraging better adherence 
to practice guidelines. In early 2013, an interest among the Clinic’s collaborative team developed 
an initiative to screen mothers for PPD. The initiative was ignited after several pediatricians and 
the supervising clinical psychologist attended a continuing education workshop titled 
Behaviorally Effective Healthcare in Practices, held by the State Chapter of the American 
Academy of Pediatrics, in conjunction with the Volunteer State Health Plan, a subsidiary of the 
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Blue Cross Blue Shield of Tennessee insurance provider. This workshop disseminated 
information on evidence-based methods of screening mothers for PPD (Earls, 2010), as well as 
practical considerations such as reimbursement. Following this workshop, Clinic providers were 
encouraged to incorporate screening practices for PPD using the collaborative team to develop a 
protocol adapted to fit the Clinic’s organization and flow. The protocol development team 
consisted of 5 pediatricians, a clinical psychologist, the current BHC, and a social work graduate 
student. 
An initial concern regarding a PPD protocol development was that the identification and 
response to mothers’ psychosocial concerns is outside a pediatrician’s scope of practice. 
Therefore, physicians relied on the extant collaborative practice model with department of 
psychology to lead the development of a protocol designed to address mothers’ psychosocial 
needs, which falls more ethically within psychology scope of practice. The team began the 
development process by meeting formally (i.e., two scheduled meetings) and informally (i.e., 
emails, in-office discussions) in the Fall of 2013. The formal meetings were used to discuss 
topics such as which screener to use, which mothers to screen, how to distribute and score the 
screeners, what actions should be taken based on significant scores, and how to respond when 
mothers endorsed the item indicating they have thoughts of harming themselves or others. 
Informal meetings involved discussing perceptions of implementation, and disseminate updates. 
Table 4 provides more specific organization and insight regarding facilitators and barriers to the 
development process. Smith, Polaha, Tolliver, and Baker (manuscript in preparation) chronicles 
a detailed discussion of the various barriers and facilitators in the development of this specific 
protocol.  
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Table 4 
Emergent Facilitators and Barriers of the Stepped-Care Protocol Organized by the Domains of the Consolidated Framework for 
Implementation Research (CFIR) 
 
CFIR domains Facilitator Barrier 
Intervention 
Characteristics 
● Evidence strength and quality: EPDS is perceived 
to be an effective in identifying mothers with PPD 
symptoms by providers, based on peer-reviewed 
literature and established organizational guidelines 
and stated best practices (TNAAP).  
● Evidence strength and quality: Provider perception 
of the finalized stepped-care protocol as 
acceptable and manageable.  
● Adaptability: The finalized protocol maintained 
“core” components of the protocol (e.g., EPDS) 
while adapting “periphery” components to best fit 
the needs and flow of the practice. 
● Cost: The EPDS screener generated revenue. 
● Cost: Development and 
implementation cost provider 
uncompensated time. 
Outer Setting ● Patient needs: the protocol fills the assessment and 
initial treatment need to screen mothers for PPD. 
● External policies: There exists an external 
standard for pediatricians to implement PPD 
screening as a part of quality care as set by 
TNAAP. 
● External incentives: Insurance companies 
reimbursed the practice for each screener 
completed by mothers. 
 
Inner Setting 
 
● Structural characteristics and culture: The 
integrated context of the clinic offers structural 
characteristics and a culture that are an important 
strength conducive to facilitating practice change 
● Readiness for implementation: Some 
providers did not fully understand the 
sequence of steps required for proper 
EHR and billing documentation. 
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and protocol implementation psychological in 
nature. 
Characteristics of 
Individuals 
● Knowledge and beliefs about the intervention: The 
positive attitudes towards this change make 
implementation more likely. 
● Self-efficacy: Low self-efficacy of 
pediatricians to identify and manage 
maternal symptoms of depression, 
given mother is not the patient. 
Process ● Engaging: A multidisciplinary team was involved 
throughout the process. 
● Executing: Making the initial “kick-off” day 
unique from other days to bring attention to the 
change in the practice behavior to clinic team. 
● Evaluating: Evaluation occurred informally 
throughout the implementation.  
● Planning: The effort and time to plan 
and coordinate of necessary team 
meetings. 
● Planning: The development of a 
documentation tool within the EHR 
was cumbersome and required the 
BHC to become familiar with a new 
system. 
● Evaluating: There has not been a 
formal evaluation or feedback 
process since the protocol began. 
 
Note. The Consolidated Framework for Implementation Research table is adapted from Robbins, Jackson, Green, Korngiebel, Forces, 
Baldwin (2013) 
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Figure 2 depicts the implementation timeline. In 2013, several formal and informal 
meetings were conducted to collect opinions, and review research. The protocol was launched as 
scheduled in January 2014 and reach was evaluated within its first month to monitor progress. 
Data on maternal satisfaction and billing records were collected immediately to evaluate initial 
implementation in 2014.  
 
 
Figure 2. Implementation Timeline  
 
Finalized Stepped Care Protocol 
The team wished to develop not only a screening method, as recommended by the State 
Chapter of the AAP, but to also expand the procedure to provide a preliminary intervention to 
mothers during their child’s WCC, based on research suggesting mother’s prefer therapeutic 
interventions over medications and follow-through on those referrals is unknown. The final 
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protocol was not based on a single intervention but on a theory-based stepped care intervention 
(i.e., Gjerdingen et al., 2008), which was adapted to best fit the needs and flow of the practice 
(see Figure 1).   
The final stepped care protocol included four distinct stages. In Step 1, the EPDS was 
distributed by the front desk staff at check-in to all mothers presenting to the Clinic for a WCC 
with children 0 to 6 months of age. The EPDS was printed on purple paper to distinguish it from 
other screeners and required forms. The decision to screen mothers from 0 to 6 months was 
based on recommendations by the AAP to utilize screening during months when PPD symptoms 
are highest, which include 1-, 2-, 4-, and 6-month WCC (Earls, 2010).  
 In Step 2, the EPDS was scored by the pediatrician, documented in the child’s note 
within EHR as “non-significant” (score = 0 – 8), “At-Risk” (score = 9 –11) or “Clinically 
Significant” (score > 12). Screening results were sent to the mother’s Primary Care Provider 
(PCP) or OB/GYN, and pediatricians indicated the EPDS Current Procedural Terminology 
(CPT) code (99420), which is used for health risk assessments, on the Clinic’s billing sheet.  
Steps 3 and 4 were only employed if warranted and involved the delivery of a menu of 
options that were “ordered” by the pediatrician using the embedded platform as illustrated in 
Figure 1. Step 3 was employed if a mother screened positively (i.e., “At-Risk” or “Clinically 
Significant”), or if the mother endorsed any level on item 10 of the EPDS. The mother was 
provided one or multiple of the following options: a) education via pediatrician or BHC (when 
onsite), b) a brief, evidence based intervention, such as cognitive behavior therapy, acceptance-
commitment therapy, by the onsite BHC (when on site), and/or c) a referral to an outside mental 
health provider and/or their primary care provider for medication options. The decision to 
employ one option over another was determined by the collaborative team clinical discretion. 
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Step 4 concluded the protocol and involved a one-week follow-up phone call to the patient 
conducted by the BHC or social worker who was working at the Clinic onsite (see Figure 1) for a 
visual depiction of the protocol).  
Documentation of the EPDS score (Step 2) occurred within the EHR, as did the “EPDS 
Plan of Action” (Step 3) and the follow-up phone call order to the BHC (Step 4). If the BHC saw 
the mother, then a note was placed in the chart containing details of the encounter. If a mother 
completed the EPDS, then her physician scored the measure and documented the action taken 
(i.e., “no action needed”; “education;” “referred to the BHC;” “community referral”) under the 
“History of Present Illness” section of the child’s note. In order to follow through with the 
scheduled one-week follow-up phone calls for mothers, the pediatricians could order a phone call 
that was subsequently sent to a specific “worklist” (an alert system specific to the Clinic’s 
electronic health record to notify providers of outstanding tasks related to client visits) the BHC 
could access and complete within one week. Each BHC interaction and follow-up phone call 
attempt and contact was documented within the child’s EHR chart. 
Finally, to train all necessary healthcare providers (i.e., nurses, pediatricians, 
administrative staff) on the protocol, a Grand Rounds, given in late January 2014, by a clinical 
psychology doctoral student who assisted in the development of the protocol, disseminated 
information on the Clinic implementation. At that time, the collaborative team answered 
questions and asked the Clinic staff to provide regular feedback during implementation. The first 
day of implementation was intentionally unique and highlighted as different from other days, and 
the licensed psychologist was present in the Clinic to remind the nurses and physicians of the 
protocol. Specifically, the supervising psychologist was present and made face-to-face contact 
with the attending, residents, medical students, nurses, and administrative assistants working that 
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day. 
Participants 
Participants are operationalized as the mother-child dyads seen at the Clinic. This study 
was submitted for review by the university’s Institutional Review Board and approved on 
October 30, 2015. Given the retrospective nature of the study, informed consent was not 
required. 
Research assistants reviewed the electronic medical record (EHR) notes (documentation 
of a visit with the pediatrician) within the charts of 755 patients aged 0 to 6 months between the 
dates of February 25, 2014 and February 24, 2015. Only the notes of patients attending their 1-
week, 1-month, 2-month, 4-month, and 6-month WCC were collected, since the EPDS was only 
provided at those visits. Exclusion criteria included acute and follow-up visit notes.  
It was not expected that every patient would attend every WCC from 0 to 6 months. 
Patients might not have attended visits for a variety reasons (e.g., patient recently moved to/from 
the area, parents did not bring their child according to the AAP recommended intervals); 
however, the patient’s data from as many WCC as possible was captured despite missing visits. 
In an effort to capture complete information, additional data was collected for patients whose 
final visits fell on dates past the designated one year mark. Mother-child dyads who were born 
after February 25, 2014, yet prior to February 25, 2015, and had remaining WCCs, up to their 6 
month WCC falling after February 25, 2015, were included to provide more complete data; 
therefore, the final date for which data was collected fell on September 25, 2015.  
Eighteen patient files were removed due to chart restrictions or the caregiver at the 
child’s first well child check (WCC) was not the biological mother of the patient, as noted in the 
patient’s chart and therefore unable to complete the Edinburgh Postnatal Depression Scale. A 
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total of 737 patients’ (boys = 355, girls = 382) charts, for a total of 2,408 WCC, were included in 
the analyses. The age of mothers ranged from 15 to 46 years (M = 27.10, SD = 5.71) at the first 
WCC.  
 The number of WCC patients attended ranged from 1 to 5 visits (M = 3.27, SD = 1.45). 
One hundred and twenty-one patients attended just one WCC, 134 presented for two WCC, 114 
presented for three WCC, 159 presented for four WCC, and 205 arrived for all five WCC. Three 
hundred and thirty-five WCC appointments were captured for 1 week WCC, 543 for 1-month, 
472 for 2-month, 539 for 4-month, 519 for 6-month. Sixty-seven percent of all WCC notes had 
an associated EPDS scanned into the chart. 
Materials 
Edinburgh Postnatal Depression Scale (EPDS) 
The EPDS is an empirically supported instrument with well-established reliability 
(Cronbach’s α range: .87-.88) and construct validity (convergent with Research Diagnostic 
Criteria for Definite Major Depressive Illness; Cox et al., 1987), with a sensitivity of 86% and 
specificity of 78%. It is a 10-item questionnaire assessing psychological symptoms of PPD 
experienced within the past week (e.g., “I have blamed myself unnecessarily when things go 
wrong” or “I have been so unhappy that I have had difficulty sleeping”). Additionally, the EPDS 
has one item that asks directly about a mother’s thoughts of harming herself or others. A unique 
feature of the EPDS is the flexibility for a provider to administer it frequently since the 
instrument asks only about the previous week (Cox et al., 1987). Each item provides a 3-point 
Likert response scale (“yes, most of the time” = 3, to “no, never” = 0). Each item is individually 
scored and all scores are summed to arrive at a total score ranging from 0 to 30. 
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Scores 13 and higher are considered “Clinically Significant” for PPD and scores falling 
on, or between 9 and 12 help to detect those experiencing milder symptoms of depression, 
increasing the measure’s sensitivity (Cox et al., 1987; Matthey, Henshaw, Elliott, & Barnett, 
2006). The consistently validated “cut-off” score is 13 or higher (Matthey, Henshaw, Elliott, & 
Barnett, 2006); however, the “cut-off” score should not replace clinical judgment (Cox et al., 
1987; Murray & Carothers, 1990). The EPDS is not a diagnostic instrument but one that 
illuminates potential current risk. A Spanish version of the EPDS was translated by the Clinic’s 
Spanish language interpreter and was administered to Spanish-speaking families. 
For this project, three categories of scores are distinguished. Scores ranging from zero 
through 8 are considered non-significant for symptoms of PPD, scores from 9 through 12 are 
considered “At-Risk,” and scores of 13 or higher are considered “Clinically Significant.” Scores 
falling in the “At-Risk” or “Clinically Significant” range are collectively referred to as “positive 
screeners” (Matthey, Henshaw, Elliott, & Barnett, 2006).  
Procedure 
Data Collection 
Patient data was extracted from the Clinic’s EHR system. A list of eligible patients and 
billing record (i.e., reimbursement amount and insurance carrier) associated with each visit was 
obtain with the cooperation of Clinic administrative personnel in charge of EHR and patient 
billing. Aside from the principle investigator, three research assistants (RA; two psychology 
undergraduate students and one fulltime research assistant) assisted with EHR extraction. Two 
research assistants were recruited through an advertisement posted to the university’s psychology 
department listserv distributed to all undergraduate students taking at least one psychology 
course. Both students were interviewed and hired based on their academic interests and goals, as 
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well as their subjective fit with the principal investigator (PI), and under the assumption each 
would demonstrate a strong work ethic. The additional research assistant was assigned to work 
on this project, as stipulated in her employee contract. Each RA applied for and was approved to 
access patient EHR charts by EHR administrators and completed the Collaborative Institutional 
Training Initiative required of those engaged in Human Subjects Research. All three RAs were 
individually trained by the PI on how to review and collect data within the EHR in a manner 
compliant with the Human Information Portability Accountability Act. The RA’s were 
periodically reminded of the importance of performing research activities in a manner compliant 
with HIPAA regulations (i.e., using the EHR to review only the charts of patients needed to 
fulfill research needs). 
The RAs reviewed each patient’s chart starting with visits from February 25, 2014 
through September 25, 2015, and extracted information listed in the coding sheet (Appendix A) 
and recorded it into an SPSS 22 (IBM Corp., 2010) software file. It’s important to note that if the 
EPDS was scanned in the child’s chart, the RA used the score on the scanned file in place of the 
number reported in the note by the physician. Finally, to ensure accuracy of data collection 
across raters (RAs) a Cohen’s Kappa reliability coefficient of .96 was calculated to correct for 
chance agreement (McHugh, 2012) using 13.6% of the participants.  
Data Analyses 
 Aim 1: The first component of the Reach aim divided the total number of eligible WCC 
by the total number of WCC with an EPDS score recorded within the “History of Present Illness” 
section of the note yielding a percentage. The second component was measured by dividing the 
total number of WCC with a recorded EPDS score by the total number of scores that fell within 
the “positive” range (i.e., separate calculations for “At-Risk” and “Clinically Significant” were 
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computed). Finally, the third component of this aim divided the total number of positive EPDS 
screens by the total number of positive screen visits that had Step 3 (only options “a” and “b” 
were recorded) and/or Step 4 follow-up phone call, as recorded in the EHR. Aim 2: To evaluate 
effectiveness, a multiple regression was conducted to determine whether or not 1 or 2 month 
EPDS scores, “education,” “onsite BHC visit,” and “BHC follow-up phone calls” held any 
predictive value for 6 month scores. Aim 3: Adoption was measured by dividing the number of 
WCC seen from February 25, 2014 through September 25, 2015, by the number of those WCC 
charts containing an EPDS score for each pediatrician. Aim 4: Implementation examined a 
mother’s typical course of care over her child’s first 6 months across all 5 visits for mothers. This 
aim answers how closely the protocol was implemented with fidelity to the protocol developed 
by the collaborative development team. Aim 5: Maintenance examined the financial feasibility 
of the stepped care protocol by determining the total amount which the pediatric clinic was 
reimbursed between February 25, 2014 through September 25, 2015 from the extracted billing 
records.  
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CHAPTER 3 
RESULTS 
Aim 1: Reach  
 Percentages were used to determine the reach of the EPDS for each WCC.  Results 
indicate a higher percentage of WCC had documented screeners, compared to previous studies 
(Chaudron et al., 2004; Freeman et al., 2005). Specifically, 83.76% (n = 2,017) of the 2,408 
WCC had an EPDS score recorded in the patient chart (see Table 4).  
Table 4. Range of EPDS scores by WCC in percentage and N 
 Well Child Check (WCC) 
 
1 week 1 month 2 month 4 month 6 month Total WCC 
Total Visits 335 543 472 539 519 2408 
EPDS in chart 290 (86.57%) 465 (85.64%) 398 (84.32%) 456 (84.60%) 408 (78.61%) 2017 (83.76%) 
“At-Risk” 26 (8.97%) 28 (6.02%) 29 (7.29%) 31 (6.80%) 29 (7.11%) 143 (7.90%) 
“Clinically 
Significant” 
13 (4.48%) 25 (5.38%) 31 (7.79%) 36 (7.89%) 24 (5.88%) 129 (6.40%) 
“Positive” 
(combined) 
39 (13.45%) 53 (11.40%) 60 (15.08%) 67 (14.69%) 53 (12.99%) 272 (13.49%) 
Note: Cut-off for At-Risk is a score of < 9 and for clinical significance is < 13. A “positive” 
score is considered “At Risk” or “Clinically Significant” Chaudron et al., 2004; Freeman et al., 
2005Risk or above 
 
Hypothesis (b) was supported; the prevalence of depression symptoms fell within the 
range often cited by previous studies (Gaynes et al., 2005; Gold, 2002; O’Hara & Swain, 1996). 
The percentage of WCCs with EPDS scores falling within the “positive” range (combining “At 
Risk” and “Clinically Significant”) for all WCC was 13.5% (N = 272; see Table 4 for further 
breakdown by WCC). Additional information gleaned from the results, which was not initially 
hypothesized, revealed 177 (24%) mothers scored in the “At Risk” and “Clinically Significant” 
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range during at least one WCC and indicated EPDS scores ranged from 0 to 30 with the average 
score around 3 for each type of WCC (see Figure 3).   
 
Figure 3.  Average EPDS Score across WCC 
Hypothesis (c) was also supported. The percentage of WCC with an intervention ordered, 
when the EPDS score fell within the “At-Risk” (score falling between 9 and 12) or “Clinically 
Significant” (score > 12) ranges, showed pediatricians ordered an intervention and noted it in the 
chart for over 85% of patients as shown in Table 5. In addition, Table 6 shows the frequency 
with which each type of intervention (i.e., “No Action Needed,” “Education,” “Referral to 
BHC,” “Referral to Social Work,” “Community Referral,” “Brief Intervention by BHC,” “Phone 
Call by BHC,” “Phone Call by Social Worker,” or nothing recorded in note) was ordered. A 
majority of actions ordered included a “referral to BHC” and “education” (provided by 
pediatrician or onsite BHC), respectively, followed by “community referral,” “brief intervention 
by BHC,” and “Phone call by BHC.” Table 7 provides further detail regarding whether or not the 
BHC Visit actually occurred, a phone call follow-up was attempted and whether a follow-up 
phone call was achieved, as evidenced by a BHC note within the patient’s chart. 
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Table 5. Percentage of Actions Ordered  
 Well Child Check  
 1 week 1 month 2 month 4 month 6 month Total 
Number of 
Patients with 
Positive Screen 
(“At-Risk” and 
“Clinically 
Significant”) 
 
39 53 60 67 53 272 
Percentage and 
number of 
Patients with 
an Action 
Ordered 
94%  
(n = 37)  
90%  
(n = 48)  
90% 
(n = 54)  
79%  
(n = 53)  
79%  
(n = 42) 
86%  
(n = 234)  
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Table 6. Plan of Action Ordered for Mothers Scoring within the Positive range 
Plan of Action Recorded 
 1 week 1 month 2 month 4 month 6 month Total 
“Referral to 
BHC” 
48% 
(n = 19) 
49% 
(n = 26) 
35% 
(n = 21) 
31% 
(n = 21) 
42% 
(n = 22) 
43% 
(n = 118) 
“Education” 
59% 
(n = 23) 
43% 
(n = 23) 
46% 
(n = 28) 
28% 
(n = 19) 
33% 
(n = 18) 
41% 
(n = 111) 
“Community 
Referral” 
85% 
(n = 33) 
9% 
(n = 5) 
10% 
(n = 6) 
10% 
(n = 7) 
8% 
(n = 4) 
29% 
(n = 79) 
“Phone Call by 
BHC” 
36% 
(n = 14) 
23% 
(n = 12) 
30% 
(n =18) 
25% 
(n = 17) 
25% 
(n = 13) 
27% 
(n = 74) 
“Brief 
Intervention by 
BHC” 
13% 
(n = 5) 
15% 
(n = 8) 
12% 
(n = 7) 
10% 
(n = 7) 
9% 
(n = 5) 
12% 
(n = 32) 
“No Action 
Needed” 
0% 
(n = 0) 
8% 
(n = 4) 
10% 
(n = 6) 
16% 
(n = 11) 
15% 
(n = 8) 
11% 
(n = 29) 
Nothing 
Recorded 
5% 
(n = 2) 
2% 
(n = 1) 
3% 
(n = 2) 
6% 
(n = 4) 
8% 
(n = 4) 
5% 
(n = 13) 
“Phone Call by 
Social 
Worker” 
0% 
(n = 0) 
0% 
(n = 0) 
2% 
(n = 1) 
0% 
(n = 0) 
0% 
(n = 0) 
0.37% 
(n = 1) 
“Referral to 
Social Work” 
0% 
(n = 0) 
0% 
(n = 0) 
0% 
(n = 0) 
0% 
(n = 0) 
0% 
(n = 0) 
0% 
(n = 0) 
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Table 7. Actions that Occurred    
BHC-related Actions that Occurred  
“Onsite BHC 
Visit” 
37% 
(n = 15) 
54% 
(n = 27) 
36.6% 
(n = 22) 
43.3% 
(n = 29) 
35.8% 
(n = 19) 
41.2%  
(n = 112) 
“Phone Call 
Follow-up 
Contact” 
22.5%  
(n = 9) 
1.9% 
 (n = 1) 
23.3%  
(n = 14) 
8.96% 
 (n = 6) 
11.3%  
(n = 6) 
13.2%  
(n = 36) 
 
Aim 2: Effectiveness 
The hypothesis regarding the effectiveness of the interventions (“education,” “onsite 
BHC visit,” “BHC phone follow-up call contact”) delivered to mothers falling within the “At-
Risk” and “Clinically Significant” ranges of the EPDS at their child’s 1- or 2-month WCC was 
explored using a multiple regression. The multiple regression was specifically used to determine 
if 1- or 2-month WCC EPDS scores predicted outcomes at the 6-month WCC. Only mothers who 
attended both a 1- or 2- month WCC, and scoring in the “At Risk” or “Clinically Significant” 
range (Time 1), and had a 6-month WCC EPDS noted in the chart (Time 2), were included in the 
analysis. Thirty (9.43%) mothers had a positive screen noted in their child’s chart (“At-Risk,” n 
= 18; “Clinically Significant,” n = 12) at 1- or 2- months and 27 (8.50%) had positive screens 
(“At-Risk”, n = 16; “Clinically Significant,” n = 11) at 6 months. Results indicate that Time 1 
scores were predictive of Time 2 score, and the type of intervention did not contribute uniquely 
to the Time 2 score.  
Analysis results of a multiple regression are shown in Table 8. The hypothesis that the 
interventions provided would significantly lower EPDS scores at 6-month WCC was not 
supported. Of the four independent variables only Time 1 (1- or 2- month WCC) resulted in a 
statistically significant (p < .05) explanation of variance for the dependent variable, 6-month. 
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Overall, the model accounted for 37.7% of the variance in the 6 month score, F(4, 26) = 2.348, p 
< .082, R2 = .27. 
Table 8. 
 
Multiple Regression Model 6 Month EPDS Score 
 
Independent 
Variable 
b 
 
SEB β t Sig 
1- or 2- month .81 .29 .50 2.82 .009* 
Education -2.50 2.28 -.20 -1.20 .285 
Onsite BHC 
Visit 
-3.47 2.33 -.27 -1.50 .150 
BHC follow-
up phone call 
contact 
.654 4.66 .03 .14 .889 
Note. R2 = .27 
*p<.05 
Aim 3: Adoption 
 The hypothesis regarding adoption of the screener explored the percentage of WCC that 
had an EPDS documented in the child’s note. The hypothesis was supported. Both preceptors 
and residents, ranged from 67.42% to 100%, with 83.74% of all notes including an EPDS score, 
which surpasses the hypothesized rate of 50% indicated by previous literature (Chaudron et al., 
2004; Freeman et al., 2005). See Table 9 for additional details across pediatricians (de-
identified). 
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Table 9. Adoption by Provider 
Pediatrician Number of Notes Number of Notes with EPDS Percentage 
A 11 11 100% 
B 58 55 94.82% 
C 435 389 89.43% 
D 514 457 88.91% 
E 683 584 85.51% 
F 158 124 78.48% 
G 305 237 77.70% 
H 152 117 76.97% 
I 89 60 67.42% 
Total 2405 2014 83.74% 
 
Aim 4: Implementation 
  The hypothesis regarding Implementation examined the integrity of the protocol. To 
explore this hypothesis only the mothers who arrived with their child to all 5 WCC were 
included in analyses. Based on the following results, the hypothesis was supported and the 
protocol appears to have been implemented as intended. A total of 205 patients were seen for all 
5 visits between February 25, 2014 and September 25, 2015. A combined total of 1,025 WCC 
had a documented EPDS score (99 visits did not have a documented EPDS score).  Thirty 
(14.63%) mothers scored “positive” during one WCC. Twelve (5.85%) mothers screened 
“positive” at two WCC. Five (2.44%) mothers at three WCC. Six (2.93%) mothers at four WCC, 
and only one (.49%) mother screened “positive” at five WCC. Of the mothers scoring within the 
“positive” range, 100% received an intervention for each visit.  
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Aim 5: Maintenance 
 Based on preliminary data, it was hypothesized the EPDS reimbursement rates would 
generate approximately $15,000 in one year. Results collected from the billing records indicate 
that the clinic received a cumulative amount of $21,028 across 17 months as calculated by 737 
chart reviews, which averages to about $28.51 per EPDS. EPDS reimbursement rates ranged 
from $0 to $35. This reimbursement rate exceeded the hypothesis amount of $15,000. 
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CHAPTER 4 
DISCUSSION 
Postpartum depression is a public health concern, occurring in 10% to 20% of mothers 
(Gaynes et al., 2005), with the potential to negatively impact maternal, child, and family 
wellbeing (Beck, 1995; Beck, 2001; Essex, Klein, Cho, & Kalin, 2002; Lara & Klien, 1999; 
NICHD, 1999; Stewart et al., 2003). Children with mothers experiencing symptoms of PPD are 
at an increased risk for slower development, an increased number of behavioral and emotional 
concerns, and these mothers are less likely to adhere to safety recommendations (e.g., improper 
car seat use; Norhayati et al., 2015). If moderate to severe forms of PDD are left untreated, 
symptoms are unlikely to remit and can persist for years (O’Hara & Swain, 1996). Fortunately, 
effective treatments in the form of psychotherapy and psychopharmacology are available 
(NIHCM, 2010) but, often, mothers encounter barriers to these treatments (e.g., time, cost, 
stigma; Gjerdingen et al., 2008; Heneghan et al., 2004; Koniak-Griffin et al., 2006; NIHCM, 
2010).  
This study contributes to the PPD screening and treatment literature by: 1) describing the 
application of an empirically-informed method (Gjerdingen et al., 2008) with which to deliver 
both PPD screening and innovative follow-up care that includes brief psychotherapy in a 
pediatric primary care clinic; 2) serving as a standard replication study for the screening portion 
of the protocol to improve rates of screening for PPD; 3) evaluating various components of 
implementation feasibility so other pediatric primary care clinics may glean information helpful 
to develop and execute a protocol that is effective and efficient, and to offer an example with 
which to compare their results, and finally; 4) describing the functions behavioral health 
consultants serve as valuable pediatric team members within pediatric primary care settings as 
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strengths of the protocol. The RE-AIM model (Brownson, Colditz, & Proctor, 2012) is the 
scaffolding used to present outcomes.  
Feasibility of Protocol (RE-AIM) 
Aim 1, Reach, is intended to assess the willingness of the target population to participate 
(Glasgow, Vogt, & Boles, 1999). Though mothers did not have a choice, as the EPDS was 
included in the required paperwork for their child’s WCC visit, results showed a vast majority of 
mothers were screened, as evidenced by the presence of an EPDS score documented in a 
majority of the WCC notes (83.76%). These results are encouraging, as screening rates for this 
clinic far exceeded previous studies which reported approximately 50% of mothers were 
screened during their child’s WCC (Chaudron et al., 2004; Freeman et al., 2005), and are within 
striking distance of the American Academy of Pediatrics’ (AAP) practice guidelines to screen all 
mothers for PPD within the first year of having a child (Earls, 2010).  
It is conceivable the reach of the screening tool may be even higher in actuality. Some 
pediatricians may have administered the verbal 2-item depression screener, as it is an alternate 
practice recommended by the AAP (Earls, 2010), and failed to record the results, or documented 
the results elsewhere, suggesting screening might have been conducted, but was not captured by 
the data collection methods used for this study.  
This study also examined the rates of screening across the first five WCCs (1 week, 1 
month, 2 month, 4 month, and 6 month), whereas Chaudron et al. (2004) intended to screen at all 
WCC’s during the first year and Freeman et al. (2005) only screened at the child’s 2 month 
WCC. This study suggests it is feasible to maintain a steady screening rate across multiple 
WCC’s, with 86.57% of mothers being screened at the 1 week WCC and 78.61% at the child’s 6 
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month WCC. Screening at five WCCs, instead of one, may have helped to establish it as a habit 
within the practice. 
Consistent with previous research, “positive” screens fell between 10% and 20% for this 
clinic with 11.4% being the lowest rate at the 1 month WCC and 15.08% being the highest rate at 
the 6 month WCC (Gaynes et al., 2005; Gold, 2002; O’Hara & Swain, 1996); however, it is 
surprising these rates are not higher considering a majority, approximately 70%, of families 
served by this clinic hold Medicaid health insurance plans, and research has shown low-income 
families report higher rates of PPD (Isaacs, 2004). 
Not only was this study able to demonstrate the feasibility of screening new mothers for 
PPD at their child’s pediatrician’s office with improved screening rates, but it also suggests that, 
when collaborative care is available (Dennis, 2005; Gjerdingen et al., 2008; Gilbody, Bower, 
Fletcher, Richards, & Sutton, 2006; USPSTF, 2002), it is feasible to ensure mothers have access 
to immediate follow-up care in various forms. For this clinic, follow-up care included delivery of 
brief psychoeducation by a pediatrician or a BHC, and same-day brief interventions provided by 
the BHC to mothers.  
The most common referral ordered, ranked from most to least frequent, included Referral 
to the “BHC,” “Education,” “Community Referral,” and “Phone Call by BHC”. Only 11% of 
WCC with “positive” screens had “No Action Needed” attached to the note, suggesting the 
pediatrician made a conscious decision to incorporate clinical judgment and deemed the services 
offered in the clinic were not necessary. Reasons for not ordering a follow-up service at that time 
are speculative, but it may be that the mother was already receiving treatment from a mental or 
medical health professional to address her depressive symptoms (Gjerdingen et al., 2008). The 
least utilized options were the referral to and the phone call by the social worker. The graduate 
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student social worker, between February 25, 2014 and September 2015 was located in the office 
but in a separate location away from the exam room and the BHC. Additionally, social work 
coverage was less frequent than the BHC, averaging one day a week, versus BHC coverage that 
range from 3 to 5 days a week. Both variables may have contributed to the underutilization of the 
social worker. 
These results suggest this protocol is a highly effective method of ensuring mothers who 
screen for symptoms of PDD are at least given the option of coming into immediate contact with 
evidence-based treatment. These results have strong implications for the way PPD is treated in a 
pediatric primary care setting. These services offer a method with which to overcome barriers 
that might otherwise impede a mother from receiving follow-up therapeutic services (e.g., time, 
stigma, cost; (Gjerdingen et al., 2008; Heneghan et al., 2004; Koniak-Griffin et al., 2006; 
NIHCM, 2010). 
The concept of adoption, Aim 3, does not deviate significantly from reach, and can be 
discussed subsequent to the previous domain. Both domains measure the extent to which the 
EPDS screener was administered and scored, as measured by the proxy variable of 
documentation, but adoption examines the rate of adoption per each pediatrician. As expected, 
given the results from Aim 1, the overall pediatrician adoption was high. However, the range of 
adoption across pediatricians ranged from approximately 67% to 100%.  
The discrepancy in adoption across pediatricians could be explained by multiple 
operative factors. First, the discrepancy may reflect the number of days of the week the 
pediatrician spent in the Clinic; pediatricians spending more days in the Clinic might have more 
opportunities to develop a more reliable routine than those working fewer hours or days. 
Additionally, some pediatricians might have been absent during the grand rounds presentation 
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that occurred in January 2014, prior to implementation, which was meant to prepare pediatricians 
of the practice change; however, grand round attendance data was not collected, therefore, we 
are unable to make sound conclusions about attendance and rate of adoption for each 
pediatrician. Another possible explanation could be that maternal mental health may not be 
considered a priority for that pediatrician and may have been a topic overlooked more frequently 
(Olson et al., 2002), despite it being part of the AAP Anticipatory Guidelines for that age range 
(Earls, 2010). Finally, the pediatrician may not have worked on a day with BHC coverage during 
the earlier months of this study, since BHC coverage was limited to 3 day, instead of the 5 days 
of coverage that began in the summer of 2015. Thus, the visual reminder of having a BHC 
present may not have been there to prompt the pediatrician.  
Though this study demonstrated improved rates of PPD screening, Yawn et al. (2012) 
encouraged future studies to report on maternal outcomes of programs that attempt to screen, 
diagnosis and initiate treatment for mothers with PPD. Aim 2, effectiveness, attempted to 
examine maternal outcomes. A significant decrease in EPDS scores from 1- and 2-month WCC 
to 6-month WCC was found. However, the interventions (i.e., “education,” “onsite BHC visit,” 
and “BHC phone follow-up call contact”) did not significantly contribute to the overall improved 
scores at the 6-month visit. The lack of clinical significance, as it relates to the interventions, 
associated with the drop in symptoms could be a result of a natural resolution of symptoms, as 
suggested by Horowitz and Goodman (2004). The small sample size (N = 30) and the lack of a 
waitlist, or treatment as usual group, weakens the ability to make meaningful statistical 
comparisons and generalizations. Further discussion of ways to improve this analysis is 
addressed below, in the Future Directions section. 
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As hypothesized in Aim 4, Implementation, mothers screening high on the EPDS made 
contact with more services (e.g., brief therapy with BHC and follow-up phone) compared to 
those screening within the non-significant level. Further, it is interesting to note that mothers 
scoring in the “Clinically Significant” range either received a higher quantity, or number, of 
services compared to those in the “At-Risk” range, or more intense types of services, such as 
brief therapy versus, or in addition to, education. Some mothers screening within the non-
significant range also received services as if they had fallen into the “At-Risk” or “Clinically 
significant” ranges, which suggests some pediatricians may have employed clinical discretion 
and assigned an intervention from which they believed some mothers might benefit though their 
EPDS was not positive. This represents an appropriate implementation of clinical judgment. As 
with any mental health screener, it is important not to rely solely on one outcome measure, but 
instead to consider all available information and suggest treatment based on multiple sources of 
information (Gjerdingen & Yawn, 2007). For example, a mother may have scored within the 
non-significant range on the EPDS, but endorsed Item 10 (i.e., “The thought of harming myself 
has occurred to me”), which automatically leads to a BHC referral. 
Though a majority of the protocol components were achieved, Step 4 (i.e., phone call 
made by the BHC) did not occur as frequently as planned. This was the least utilized step of the 
protocol. Only 13% of the mothers who screened “positive” for symptoms had documentation 
that a BHC was able to contact and discuss symptoms and functioning with the mother. The low 
rate of contact could be that BHC did not have much time throughout the work day to make 
those phone calls. The nature of an integrated BHC is to be physically visible, which often means 
the BHC is not sitting behind a desk but moving throughout the clinic hallways, with the 
intention of being available to any provider at any time. This flexibility may have interfered with 
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the BHC’s ability to organize their time effectively to make phone calls, especially if the BHC 
was preoccupied managing other behavioral health concerns. Alternatively, the mother may not 
have had a working number, which happens frequently with low-income families who do not 
always have funds keep a phone number consistently active.  
Maintenance, or sustainability, of a protocol is critical when considering implementation 
of a new protocol. One aspect of sustainability is the cost benefit. Results indicated the clinic 
generated $21,028 within 17 months, which surpasses the extrapolated anticipated amount of 
approximately $15,000 from preliminary data. This protocol takes time out of the pediatricians’ 
and the BHCs’ schedules, which can take time away from other reimbursable activities; 
however, the ability to bill for the EPDS allows a Clinic to cover the time of those most involved 
in the protocol development, execution, and maintenance. In addition to the clinical care training, 
the clinic was also informed on how to bill for the Health Risk Assessment code when the EPDS 
was administered, scored and documented in the note. This revenue has the potential to be higher 
since some pediatricians candidly noted they did not remember to bill for the code on the billing 
sheet for every visit. Further, the initial language used on the billing code was “Health Risk 
Assessment” but then changed to “Edinburgh Postnatal Depression Scale” to promote clarity and 
more consistent EDPS billing practices. 
Strengths 
Strengths of this office that contributed to the marked success of the reach and adoption 
of the screener protocol implementation are multiple, at the core of which was having a 
behavioral health consultant as an integral team member throughout the development and 
implementation of the protocol. Indeed, a systematic review of PPD psychosocial treatment 
literature suggests that coming into contact with a mental health professional soon after 
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childbirth can help to ameliorate PPD symptoms (Dennis, 2005). This was a training setting, 
which suggests keeping up with best practice guidelines are at the forefront of the clinic’s 
mission to train a new generation of professionals in the most up-to-date best practices. The 
Level 5 model of integration (Heath, Wise Romero, & Reynolds, 2013) allowed for easy and 
immediate access to a BHC when needed, rather than having mothers make a follow-up 
appointment with a member in the community, a practice supported by research (Gilbody et al., 
2006). Even when mothers required outside referrals, the BHC served as the point person with 
the intention of ensuring follow-up referrals were made. Finally, the BHC role was fulfilled by 
clinical psychology doctoral students completing a required practicum experience for their 
education and were paid by separate grants obtained by the university; therefore, the clinic did 
not have to address billing concerns related to BHC provider time, so less time was spent 
determining payment. Attempts to implement a similar protocol in other settings may encounter 
barriers with insurance reimbursement restrictions and may need to negotiate with insurance 
agencies about how to most successfully reimburse for services provided to the mother. 
Limitations 
 Due to the real-world nature of this study there are numerous limitations to highlight. 
One limitation some researchers may identify is the seeming lack of rigor. Randomized 
Controlled Trials (RCTs) are regarded as the gold standard in scientific rigor. However, this 
study arguably helps to close the temporal gap between research conducted in controlled 
environments and real-world practice. RCTs are functional means of gleaning valuable 
information, but fall short in adaptability to fit into existing practices as variables in the real-
world are infinite and unpredictable. Practice-based evidence (Green, 2006), such as this study, 
is intended to be a quick and flexible method of informing practice in the moment, using data in 
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EHRs and informal interviews to inform practice changes (Glassgow, 2014) and to disseminate 
relevant findings to those who can use it (Chambers, 2016). 
This Clinic faculty and staff referred to empirical findings to inform clinical choices, such 
as using the EPDS and treating mothers with psychotherapy; however, the premise of the current 
study was to provide an example of a method to evaluate a real-world intervention and to do so 
without needing to conduct an RCT for reasons of practicality, as most healthcare service 
providers are not tasked with a mission to conduct research, nor are there extra resources and 
time. The RE-AIM model offers an alternative avenue for practice evaluation. From a RE-AIM 
perspective, a limitation of this study was its inability to compare the implementation to other 
practices. Future studies may be able to compare their results with this clinic using the same 
framework. 
Another notable limitation is the absence of clear outcome data regarding maternal 
outcomes. Though meaningful preliminary data for the first year of the stepped care protocol 
implementation was found, its insufficient robustness leaves unanswered questions about the 
effectiveness of the BHC services. Consistent with the charge put forth by Olin et al. to conduct 
more outcome research on the use of BHCs in primary care, more outcome data must be 
collected to provide more substantial evidence that BHC services provided within a pediatric 
primary care office are effective in treating more mild forms of postpartum depression in 
mothers.  
An additional limitation to the generalizability is the ability to find mental health 
providers who can treat depression in adults. The BHCs working at the Clinic receive generalist 
training within their program of study and have experience working with adults and children. 
BHCs with only child training may feel that treating mothers, even with brief therapy modalities, 
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is outside their professional scope; therefore, a training on how to address and treat mothers with 
mild to moderate symptoms of depression may be required as a best practice. The model may be 
better suited for a BHC working in a family medicine practice that sees a range of ages. 
Given the large scope of this project to examine the feasibility of this project as it 
functions as a whole, there remain some components that require further examination and 
adjustment in order to contribute to the best practice literature. Though the psychoeducation 
provided to mothers was generally standardized across providers, the treatment delivered in the 
brief intervention pieces was not standardized across BHCs. Each BHC was familiar with 
Cognitive Behavioral Therapy as an evidence-based treatment for depression, but all had been 
more recently trained in Acceptance and Commitment Therapy (ACT), specifically Focused 
Acceptance and Commitment Therapy (FACT,) and were inclined to use that modality of 
treatment over others; however, the type of therapy and activities presented, discussed, and 
practiced were not tracked or evaluated, nor was that the focus of this project. Previous research 
does suggest, overall, that most psychotherapies are equal in potency and that differences in 
outcomes are potentially negligible (Smith & Glass, 1977). 
Future Directions 
Future directions for researchers and clinicians should focus on replication of this 
intervention in other pediatric practices to elucidate other barriers that may not have been 
apparent in this setting. Further exploration of the effectiveness of the various behavioral health 
interventions (e.g., psychoeducation, psychotherapy) is important when considering whether on-
site services enhance access to care that works to reduce symptoms. For this effectiveness to be 
more thoroughly evaluated, a more standardized menu and delivery of services must occur and 
must be applied across several years to gather a large enough sample size to improve the 
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robustness of results. Possible waitlist control and treatment as usual trials could also contribute 
to rigorousness of a future study. However, future studies will need to think critically about the 
ethical implications of waiting to provide treatment since the symptoms of depression can 
directly impact the child’s development during a critical period. Future studies should also 
measure maternal satisfaction regarding the protocol procedure. Studies exploring maternal 
satisfaction could also explore maternal preferences for type of care (e.g., primary care versus 
traditional outpatient mental health services). Mothers typically appreciate their child’s 
pediatrician inquiring about their own mental health and prefer therapies to address those 
concerns over medication. Additional exploration could be conducted to determine if mothers 
value in-Clinic mental health services provided by their child’s pediatrician’s office over 
outpatient services. Future directions may also include standardizing a brief intervention 
treatment delivery package to determine the most potent therapeutic modality for mothers with 
postpartum depression. Various treatment modalities could be examined to see which one best 
fits the needs of the families and the setting of a pediatric setting. This may be best explored as 
an independent study instead of within the context of a larger study. 
Future studies should also conduct a thorough cost-benefit analysis to quantify the 
financial need to support a mental health professional to address maternal mental health. This 
could be of importance when advocating for protocol implementation and policy change. In 
addition to using the RE-AIM model, at a set number of intervals to monitor progress and 
provide data to inform Clinic practices (Glasgow, 1999) within this practice. The RE-AIM 
framework can be applied to other pediatric primary care practices to create a consistent 
mechanism with which to discuss the strengths and weaknesses of the protocol model and its 
generalizability across locations.  
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Implications and Conclusions 
 The implementation successes of this study suggest screening and treating mothers with 
symptoms of PPD can be feasible when delivered in a stepped care format, and should be 
considered as an option for best practice in all pediatric offices. Yawn et al. (2012) urged future 
studies to report on maternal outcomes in addition to procedural outcomes related to screening, 
detection and referral success. While this project is limited in its ability to report robust maternal 
outcomes, results do support the feasibility of providing mothers with a range of immediate and 
accessible interventions (e.g., psychoeducation, brief therapy) directly in pediatric primary care 
practices, referring only the most severe of cases (e.g., chronic severe depression, current 
suicidal ideation) to outside providers. Since the EPDS is a reimbursable scale, with variable 
reimbursement rates depending on insurance company, the revenue can theoretically support 
some functions of BHCs, who may otherwise encounter difficulties billing for their time working 
with mothers. This method of generating revenue may be employed until insurance policies 
adjust to fit the needs of families and offer reimbursement of adult services within a pediatric 
setting, as research shows improved maternal mental health is critical to healthy family and child 
development and future functioning.  
 A final implication of this study reinforces the need and role for BHC to be situated 
within pediatric primary care settings and further, highlighting a need for those BHCs to be 
equipped with training and skills needed to work with adults to provide immediate care for 
mothers with depression.  
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APPENDIX 
Postpartum Depression Stepped Care Protocol Coding Key 
 
Instructions: Please populate excel sheet/cells with available information/data. If information is 
not provided regarding a visit leave the cells blank.  
 
Patient Name:  _____  
 
Unique Patient ID: _____  
 
Coder Initials:  _____  
 
Sex of Patient:  _____ 
 
Mother’s Age:  _____ 
  
Relationship to the Child: 0 = assumed biological mother; 1 = foster/adoptive mother; 2 = 
grandmother  
 
Insurance Carrier: 0 = BCBC TN; 1 = Blue Care; 2 = United Healthcare 
 
Visits: Newborn; 1 week; 1 month; 2 months; 4 months; 6 months 
Date of Visit:   _____ 
 
Provider: 0 = Attending M; 1 = Attending J; 2 = Attending S; 3 = Attending S; 4 = Attending Tl; 
5 = Attending G; 6 = Attending Ma; 7 = Attending P; 8 = Resident 
 
EPDS in note:  0 = no; 1 = yes 
 
EPDS score:   _____ 
 
Action Taken: 0 = no action needed; 1 education about postpartum depression provided; 2 = 
referred to in-clinic BHC; 3 = referred to in-clinic SW; 4 = community referral; 5 = brief 
intervention provided by in-clinic BHC; 6 phone call follow-up by BHC; 7 = phone call follow-
up by SW 
 
BHC visit: 0 = no; 1 = yes 
 
BHC f/u phone call conduct (presence of a f/u note): 0 = no; 1 = yes 
 
EPDS in chart paper: 0 = no; 1 yes 
 
Associated EPDS billing code 99420: 0 = no; 1 = yes 
 
Amount Clinic charged insurance company:  _____ 
 
EPDS reimbursement amount: _____ 
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